Citations

Citations to this article as recorded by  

• Engineered exosomal delivery of semaglutide activates SIRT1–FOXO3a–miR-124 signaling and protects against cortical neuroinflammation
  Elsayed A. Elmorsy, Sameh Saber, Ahmed Y. Kira, Manal Mohamed Hatem, Mohammed Alorini, Suzan Awad AbdelGhany Morsy, Hamad Alsaykhan, Abdulaziz A. Alsalloom, Nahla B. Mohamed, Norah Suliman Alsoqih, Rabab S. Hamad, Youssef El-Sayed, Nagwa Mahmoud Ramadan,
  Journal of Drug Delivery Science and Technology.2026; 118: 108078.     CrossRef
• Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations
  Nimet Yılmaz, Mehmet Bastemir
  Diabetes, Metabolic Syndrome and Obesity.2026; Volume 19: 1.     CrossRef
• Glucagon-Like Peptide-1 Receptor Agonists and Acute Pancreatitis: Current Evidence and Clinical Implications
  Kwang Hyun Chung, Jaihwan Kim
  The Korean Journal of Pancreas and Biliary Tract.2026; 31(1): 1.     CrossRef
• Single vs. Dual Agonist Pharmacotherapy for Managing Insufficient Weight Loss and Weight Regain Following Metabolic and Bariatric Surgery: A Comparative Review
  Claudia Reytor-González, Martín Campuzano-Donoso, Gerardo Sarno, Martha Montalvan, Raquel Horowitz, Gianluca Rossetti, Vincenzo Pilone, Luigi Barrea, Giovanna Muscogiuri, Luigi Schiavo, Daniel Simancas-Racines
  Nutrients.2026; 18(4): 553.     CrossRef
• Oral Administration of Crocus sativus Tepals Extract Restores High‐Fat Diet‐Induced Gut Dysbiosis and Modulates Intestinal Inflammation and Hepatic Lipid Metabolism
  Biljana Bursać, Miloš Vratarić, Ljupka Gligorovska, Luisa Bellachioma, Ana Teofilović, Danijela Vojnović Milutinović, Camilla Morresi, Elisabetta Damiani, Tiziana Bacchetti, Ana Djordjevic
  BioFactors.2026;[Epub]     CrossRef
• Response to comment on “Efficacy and safety of GLP-1 receptor agonists in the management of obstructive sleep apnea in individuals without diabetes: A systematic review and meta-analysis of randomized, placebo-controlled trials”
  Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam
  Sleep Medicine.2025; 134: 106709.     CrossRef
• Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025)
  Shikha Patel, Sarfaraz K. Niazi
  Pharmaceutics.2025; 17(8): 1036.     CrossRef
• GLP-1 Receptor Agonists in Mood Disorders: A Psychiatric Perspective
  Pietro Carmellini, Alessandro Cuomo, Maria Beatrice Rescalli, Andrea Fagiolini
  Life.2025; 15(9): 1422.     CrossRef
• Development of a risk prediction model for gastrointestinal adverse events associated with semaglutide administration in patients with type 2 diabetes mellitus
  Deyong Yue, Xuesheng Hua, Ling Zhu, Jun Wang, Lihua Gu, Zhengxia Yuan, Wenle Jian, Yirong Chen, Guoliang Meng
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist Therapy: The Emerging Role of Oral Agents
  Sherry Yun Wang, Ryan Stofer, Hao Wang, Gregory A. Brent, Lu Shi, Yu Cai, Moom Roosan, Tannaz Moin
  Diabetes & Metabolism Journal.2025; 49(6): 1331.     CrossRef
• Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver Disorders
  Ralf Weiskirchen, Amedeo Lonardo
  Medical Sciences.2025; 13(4): 265.     CrossRef
• Seizure recurrence after GLP‐1 receptor agonist initiation in adults with epilepsy
  Majd A. AbuAlrob, Abdullah Hussein, Rand Abdellatif, Adham Itbaisha, Khaled Zammar, Boulenouar Mesraoua
  Epilepsia.2025;[Epub]     CrossRef
• Nutrient-Stimulated Hormone-Based Therapies: Transforming Obesity Management
  Ki Hoon Kwak, Chang Hee Jung
  Endocrinology and Metabolism.2025; 40(6): 879.     CrossRef
• Research Progress of GLP-1 Receptor Agonists in the Treatment of Alzheimer’s Disease
  琳娜 勾
  Advances in Clinical Medicine.2025; 15(12): 2047.     CrossRef

Citations

Citations to this article as recorded by  

• Trends in nephrology: kidney metabolism as a therapeutic target
  Jessica S Kleer, Markus M Rinschen
  Nephrology Dialysis Transplantation.2026; 41(2): 193.     CrossRef
• Sodium‐glucose cotransporter 2 inhibitor ameliorates thiazolidinedione‐induced fluid retention through vascular leakage reduction in white adipose tissue
  Ji Yoon Kim, Hye‐Min Jang, Hye‐Jin Lee, Ah Hyeon Lee, Dong‐Hoon Kim, Sin Gon Kim, Nam Hoon Kim
  Diabetes, Obesity and Metabolism.2026; 28(3): 1764.     CrossRef
• Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex
  Changyuan Yang, Petra Denig, Lynne Chepulis, Ryan G. Paul, Jung‐Im Shin, Ron T. Gansevoort, Priya Vart
  Diabetes, Obesity and Metabolism.2026; 28(3): 2265.     CrossRef
• Diabetic kidney disease: integrating multi-omics insights, artificial intelligence, and novel therapeutics for precision medicine
  Tao Li, Kaili Chen, Yiting Sun, Linqi Zhang
  Frontiers in Genetics.2026;[Epub]     CrossRef
• Nobiletin Ameliorated the Development of Diabetic Kidney Disease via Modulating Ferroptosis and Epithelial–Mesenchymal Transition Involving Gut–Kidney Axis
  Tingting Zhao, Chuyun Zhao, Qian Xiang, Xi Zhang, Kin-Fong Hong, Peiyu Liu, Zhongyan Sun, Yadi Liu, Ruiting Huang, Yiran Li, Hio-Fai Cheong, Yuwei Wu, Yingqiu Mo, Yiduo Xu, Yingxi Zhao, Qiruo Huang, Ying Xie, Youhua Xu
  The American Journal of Chinese Medicine.2026; 54(01): 303.     CrossRef
• Bridging Innovation and Practice in Type 2 Diabetes Mellitus: Novel Antidiabetic Therapies and the Expanding Role of Community Pharmacists
  Marios Spanakis, Agapi Fournaraki, Frantzeska Nimee, Christos Kontogiorgis, Emmanouil K. Symvoulakis
  Pharmaceuticals.2026; 19(2): 271.     CrossRef
• Diabetic kidney disease in northwest Ethiopia: Prevalence and determinants among adults with type 2 diabetes
  Workagegnehu Hailu, Tadesse Asmamaw Dejene, Markeshaw Tiruneh, Meseret Derbew Molla, Eshetie Melese Birru, Shitaye Alemu, Tadesse Awoke, Francesca D'Addio
  PLOS One.2026; 21(2): e0343210.     CrossRef
• The Role of Non-Coding RNAs in the Pathogenesis and Progression of Diabetic Kidney Disease
  Yinfeng Guo, Yonghao Feng, Henglan Wu, Huanqing Gao
  International Journal of Molecular Sciences.2026; 27(5): 2352.     CrossRef
• Special Issue “Molecular Therapeutics for Diabetes and Related Complications”
  Kota V. Ramana
  International Journal of Molecular Sciences.2025; 26(12): 5585.     CrossRef
• Targeting ion channel networks in diabetic kidney disease: from molecular crosstalk to precision therapeutics and clinical innovation
  Wenfeng Wang, Bi Ke, Chen Wang, Xiaojing Xiong, Xiuyuan Feng, Hua Yan
  Frontiers in Medicine.2025;[Epub]     CrossRef
• SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome
  Aryan Gajjar, Arvind Kumar Raju, Amani Gajjar, Mythili Menon, Syed Asfand Yar Shah, Sourbha Dani, Andrew Weinberg
  Biomedicines.2025; 13(8): 1924.     CrossRef
• Comparative analysis on renal and cardiovascular outcomes of antidiabetic treatment in chronic kidney disease patients—A systematic review and network meta‐analysis
  Peter Bramlage, Anjaly Vijayan, Treesa P. Varghese, Deepthy Melepurakkal Sadanandan, Stefanie Lanzinger, Carmen Ferrero Rodriguez
  Diabetes, Obesity and Metabolism.2025; 27(11): 6254.     CrossRef
• Type 2 Diabetes and the Multifaceted Gut-X Axes
  Hezixian Guo, Liyi Pan, Qiuyi Wu, Linhao Wang, Zongjian Huang, Jie Wang, Li Wang, Xiang Fang, Sashuang Dong, Yanhua Zhu, Zhenlin Liao
  Nutrients.2025; 17(16): 2708.     CrossRef
• Nutriomics and artificial intelligence nutrition obesity cohort (NAINOC): a design paper for a prospective cohort for nutrition and obesity research
  Minyoung Lee, Sungha Park, Soo-Hyun Park, Ho-Young Park, Yu Ra Lee, Min-Sun Kim, Miso Nam, Jangho Lee, Hyein Seo, Yong-ho Lee, Chan Joo Lee, Jae-Ho Park, Hye Hyun Yoo, Hyun-Jin Kim, Kyong-Oh Shin, Yoshikazu Uchida, Kyungho Park
  Clinical Hypertension.2025;[Epub]     CrossRef
• Microvascular Outcomes of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Type 2 Diabetes: A Systematic Review of Retinopathy and Nephropathy Evidence
  Atia Arif, Sanu Lama, Bhavna Singla, Shivam Singla, Sunita Kumawat, Anusha Tharwani, Muhammad Usman, Hamna Khalid, Venkata Madusudana Rao Kanukollu, Osatohanmwen Ekomwereren, Shabir Khan
  Cureus.2025;[Epub]     CrossRef
• Integrating UHPLC-QE-MS and Bioinformatics with Experimental Validation Reveals MAPK/FOS-Mediated Podocyte Apoptosis as the Key Mechanism of Alpiniae oxyphyllae and Saposhnikovia divaricata in Treating Diabetic Kidney Disease
  Xian Wang, Lin Zhang, Rongxin Tang, Wenlong Zhang, Yiqiang Xie, Kai Li
  Pharmaceuticals.2025; 18(10): 1449.     CrossRef
• Renoprotective effect of dulaglutide in L-NAME-induced hypertensive nephropathy in rats: insight into the roles of PPAR-gamma and VEGF
  Nermeen Bastawy, Aliaa E. M. K. El-Mosallamy, Rabab Ahmed Rasheed, A. S. Sadek, R. T. Khattab, Esraa Ali, Randa A. Zaghloul, Wael B. A. Ghaly, Amy F. Boushra
  Hypertension Research.2025;[Epub]     CrossRef
• GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity
  Mark E. Cooper, Daniël H. van Raalte
  Journal of Clinical Investigation.2025;[Epub]     CrossRef
• Short-Term Laboratory Outcomes of SGLT2 Inhibitor Use in Type 2 Diabetic Patients: A Retrospective Analysis
  Hamood AlSudais, Turky AlSulaiman, Badi A. Alotaibi, Abdulrahman Alshalani, Abdulaziz M. Almuqrin, Rehab B. Albakr, Jehad A. Aldali
  Journal of Clinical Medicine.2025; 14(22): 7985.     CrossRef
• Chronic cardiorenal syndrome: cardio-renal protective effect of SGLT2i
  Yixin Zhu, Chenxi Lv, Hanqi Yang, Qian Lu, XuChen Wang, Yueqi Zhang, Maojuan Guo, Bo Yang
  Renal Failure.2025;[Epub]     CrossRef
• FGF4-FGFR1 signaling promotes podocyte survival and glomerular function to ameliorate diabetic kidney disease in male mice
  Jie Zhou, Shuxin Wang, Jiaxin Lou, Beibin Pan, Min Zhao, Qian Li, Jing Zhou, Yali Du, Shuodan Ding, Meiling Yu, Jingjing Zhou, Xinwei Chen, Lingwei Jin, Xinyi Wang, Yepeng Hu, Zhe Wang, Xiaokun Li, Chao Zheng, Jian Sun, Zhifeng Huang
  Nature Communications.2025;[Epub]     CrossRef
• Food‐Herb Dual‐Function in Astragali Radix‐Poria‐Rheum: Network Pharmacology and Database Mining for Diabetic Kidney Disease Mechanisms Exploration
  Meizi Wang, Weizhong Li, Qiong Cheng, Jiayu Sun, Cheng Cheng, Nana Wang, Ping Zhou, Min Zha, Yufeng Yang
  Food Science & Nutrition.2025;[Epub]     CrossRef
• Інгібітори натрій-глюкозного котранспортера 2-го типу в контексті кардіоренально-метаболічної коморбідності. Частина 1: основи патофізіології та ключові клінічні дослідження
  Vira V. Zlatkina, Andriy O. Nesen, Nadiia V. Demikhova
  Ukrainian Journal of Nephrology and Dialysis.2025; (4(88)): 88.     CrossRef
• GLP-1 Receptor Agonists and Blood Pressure: A State-of-the-Art Review of Mechanisms, Evidence, and Clinical Implications
  Areesha Moiz, Tetiana Zolotarova, Kristian B Filion, Mark J Eisenberg
  American Journal of Hypertension.2025;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Semaglutide beyond weight loss: Mechanistic insights and functional paradoxes from the SEMALEAN study
  Shambo S. Samajdar, Shashank Joshi
  Diabetes, Obesity and Metabolism.2026; 28(1): 779.     CrossRef
• An expert narrative review on the brain-kidney axis in diabetic kidney disease: Mechanisms and therapeutic insights
  Zongrui Zhang, Rangzi Yi, Shihong Xiong, Yushu Zhang, Xuebin Cao, Wenqi Zhen, Yang Yang, Na Gong
  Diabetes Research and Clinical Practice.2026; 233: 113055.     CrossRef
• Impaired Brain Incretin and Gut Hormone Expression in Human Alcohol-Related Brain Damage: Opportunities for Therapeutic Targeting
  Suzanne M. de la Monte, Ming Tong, Rolf I. Carlson, Greg Sutherland
  Biomolecules.2026; 16(1): 99.     CrossRef
• Plasma GLP-1 (Glucagon-like Peptide-1) Depletion Is Correlated with Dysregulation of Adipocytokine in Type 2 Diabetic Patients With or Without Metabolic-Associated Fatty Liver Disease (MAFLD): A Cross-Sectional Study Related to Gender-Sex Disparities
  Zoubiri Houda, Saiah Wassila, Otmane Amel, Saidi Hamza, Makrelouf Mohamed, Aitabderrhmane Samir, Haddam Ali El Mahdi, Koceir Elhadj-Ahmed
  International Journal of Molecular Sciences.2026; 27(3): 1218.     CrossRef
• The Enterolimbic Axis: Gut-Brain Affective Circuits at the Crossroad of Metabolism, Emotion, and Behavior
  Antonio Gasbarrini, Francesca Sofia Galli, Gianluca Ianiro, Francesca Ponziani, Emanuele Rinninella
  American Journal of Gastroenterology.2026;[Epub]     CrossRef
• Micronutrient Deficiencies in the Era of Second-Generation Incretin-Based Therapies for Obesity
  Andrijana Koceva, Andrej Janež, Tajda Pečko, Mojca Jensterle
  Nutrients.2026; 18(4): 677.     CrossRef
• National Consensus on Semaglutide in Cardiology: From Clinical Evidence to Clinical Translation
  HK Chopra, Ashwani Mehta, CK Ponde, Navin C Nanda, GS Wander, Abraham Oomman, Prafulla Kerkar, SN Routray, GP Ratnaparkhi, Prashant Advani, Rituparna Shinde, Rajeev Agarwal, Ajay Mahajan, Jay Shah, Gaurav Verma, Sanjay Mittal, Dorairaj Prabhakar, D Ramesh
  Journal of The Association of Physicians of India.2026; 74(2): e8.     CrossRef
• Polysaccharides from Acanthopanax senticosus (Rupr. et Maxim.) Harms: Molecular Messengers Linking the Traditional Efficacy of Fortifying the Spleen, Replenishing Qi, and Calming the Spirit to Gut-Immune Axis Regulation
  Bichun Hu, Deyong Zeng, Junli Liu, Weiping Wang, Shuaimin Hu, Weihong Lu
  Journal of Future Foods.2026;[Epub]     CrossRef
• Obestatin: canonical and unexpected functions
  Icia Santos-Zas, Uxia Gurriaran-Rodriguez, Tania Cid-Diaz, Saul Leal-Lopez, Felipe F. Casanueva, Yolanda Pazos-Randulfe, Jesus P. Camiña
  Reviews in Endocrine and Metabolic Disorders.2026;[Epub]     CrossRef
• Hijacked Brain in Modern Obesity: Cue, Habit, Addiction, Emotion, and Restraint as Targets for Personalized Digital Therapy and Electroceuticals
  Taesung Lee, Seeun Park, Seokhyun Lee, Areum Hwangbo, HanGyeol Bae, Yumin Lee, Hyung Jin Choi
  Journal of Obesity & Metabolic Syndrome.2025; 34(3): 196.     CrossRef
• Long-Term Efficacy Trajectories of GLP-1 Receptor Agonists: A Systematic Review and Network Meta-Analysis
  Zixuan Li, Zhoubo Han, Rong Sun, Xiuping Xuan, Chenghu Huang
  Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 3611.     CrossRef
• The LEPR gene: A multifaceted regulator of energy homeostasis, obesity pathogenesis, and metabolic health
  Isar Sharma, Nishutosh, Kritika Bakshi, Ritu Mahajan, Nisha Kapoor
  Human Gene.2025; 46: 201486.     CrossRef
• Glucagon-Like Peptide-1 Receptor Agonists Are Promising for the Treatment of Brain Diseases: an Outlook from the Perspective of Integrative Physiology
  N. V. Gulyaeva
  Journal of Evolutionary Biochemistry and Physiology.2025; 61(5): 1326.     CrossRef
• Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes
  Isabel Krug, An Binh Dang, Jade Portingale, Yakun Li, Ying Qing Won
  Nutrients.2025; 17(23): 3735.     CrossRef
• A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide
  E. A. Troshina, M. B. Antsiferov, A. S. Ametov, G. R. Galstyan, T. N. Markova, T. I. Romantsova, N. V. Mazurina, O. M. Koteshkova
  Problems of Endocrinology.2025; 71(5): 19.     CrossRef
• Tirzepatide and Obesity: A Narrative Review
  Arya Singh, Rahnuma Ahmad, Kona Chowdhury, Mahendra Narwaria, Mainul Haque
  Advances in Human Biology.2025;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Implications of Glucagon-like Peptide-1 Receptor Agonists on Thyroid Function and Thyroid Nodules: A Drug Target Mendelian Randomization and Cohort Study
  Zhijun Zhang, Jingyun Yang, Ling Gao
  Endocrine Practice.2026; 32(1): 60.     CrossRef
• Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer
  Stefano Iuliano, Maria Mirabelli, Stefania Giuliano, Antonio Brunetti
  Current Opinion in Oncology.2026; 38(1): 1.     CrossRef
• Assessment of thyroid cancer risk associated with glucagon‐like peptide 1 receptor agonist use
  Tina Vilsbøll, Michael Stellfeld, Vanita R. Aroda, Sune Dandanell, Jens‐Peter David, Ceyda T. P. Kristiansen, Søren Rasmussen, Fiona L. Roberts, Laszlo Hegedüs
  Diabetes, Obesity and Metabolism.2026; 28(2): 1499.     CrossRef
• Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review
  Setor K. Kunutsor, Samuel Seidu
  Drugs.2026; 86(1): 11.     CrossRef
• Glucagon-like Peptide-1 Receptor Agonist Use and Pancreatic Cancer Risk in Patients with Chronic Pancreatitis
  Sarina Ailawadi, Jennifer E. Murphy, Michael H. Storandt, Amit Mahipal
  Cancers.2026; 18(2): 179.     CrossRef
• Mechanisms in diabetes mellitus: Relationships to metabolism and/or neoplasia
  John A. D'Elia, Bijan Roshan, Larry A. Weinrauch
  Journal of Diabetes and its Complications.2026; 40(4): 109289.     CrossRef
• Glucagon-like peptide-1 receptor agonists and the risk of obesity-related cancers: a systematic review and meta-analysis
  Yousef A. Ateiwi, Rahil Mahmood, Hon Jen Wong, Chen Ee Low, Chun En Yau, Ainsley Ryan Yan Bin Lee, Pei Chia Eng, Matilda Lee, Mark Y. Chan, Ching-Hui Sia
  Diabetes Research and Clinical Practice.2026; 234: 113158.     CrossRef
• GLP‐1 receptor agonists and the risk for cancer: A meta‐analysis of randomized controlled trials
  Giovanni Antonio Silverii, Christian Marinelli, Costanza Bettarini, Gloria Giovanna Del Vescovo, Matteo Monami, Edoardo Mannucci
  Diabetes, Obesity and Metabolism.2025; 27(8): 4454.     CrossRef
• Evaluating Thyroid Cancer Risk in Glucagon-like Peptide-1 Analog Users With Thyroid Nodules
  Sanjana Balachandra, Rohma Syed, Zhixing Song, Julia Kasmirski, Andrea Gillis, Jessica Fazendin, Brenessa Lindeman, Herbert Chen
  Journal of Surgical Research.2025; 312: 104.     CrossRef
• Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning
  Jung A Kim, Hye Jin Yoo
  Diabetes & Metabolism Journal.2025; 49(4): 525.     CrossRef
• Association between Cancer and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: A Systematic Review of Retrospective Cohort Studies
  Hyun Jin Park, Si Yoon Lee
  Research in Clinical Pharmacy.2025; 3(1): 28.     CrossRef
• GLP-1 Receptor Agonists Initiation and Risk of Acute Pancreatitis and Pancreatic Cancer: A Real-World Comparative Study
  Omar Faour, Moheb Boktor, Hanford Yau, Mustafa Kinaan, Ishak A Mansi
  American Journal of Medicine Open.2025; 14: 100114.     CrossRef
• Semaglutide and weight management in the Arab countries: Focus on the United Arab Emirates
  Sabina Semiz
  Health Sciences Review.2025; 17: 100244.     CrossRef
• GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research
  Estefania Valencia-Rincón, Rajani Rai, Vishal Chandra, Elizabeth A. Wellberg
  Journal of Clinical Investigation.2025;[Epub]     CrossRef
• GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways
  Daniela Lucente, Stefania Bellino, Anna La Salvia
  Genes.2025; 16(11): 1352.     CrossRef
• Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist Therapy: The Emerging Role of Oral Agents
  Sherry Yun Wang, Ryan Stofer, Hao Wang, Gregory A. Brent, Lu Shi, Yu Cai, Moom Roosan, Tannaz Moin
  Diabetes & Metabolism Journal.2025; 49(6): 1331.     CrossRef
• Joint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP‐1 Agonists and Thyroid Cancer
  Emma Watts, Jonathan Wadsley, Neil Sharma, Kristien Boelaert
  Clinical Endocrinology.2025;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• The influence of dapagliflozin on diabetic ocular complications: An observational cohort study
  Jo-Hsin Chen, Fei-Hung Hung, Yu-Ting Wang, Jin-Hua Chen, Shu-Fen Liao, Chun-Mei Hsueh, Jong-Shiuan Yeh, Gregory Y.H. Lip
  European Journal of Pharmaceutical Sciences.2026; 216: 107382.     CrossRef
• Diabetic retinopathy: why some eyes suffer more – a focus on retina-specific risk factors and metabolic memory
  Shanshan Tang, Linlin Jiang, Wenjie Sun, Xuedong An, Xiaomin Kang, Xuefei Zhao, Qing Gao, Zehua Li, Chenran Liu, Hangyu Ji, Fengmei Lian
  Journal of Translational Medicine.2026;[Epub]     CrossRef
• Design and Implementation of Observational Studies Emulating a Target Trial
  Yan Ren, Yulong Jia, Lingyan Liu, Houchen Lyv, Liyuan Tao, Yuezhen Li, Peng Zhao, Yiquan Xiong, Guowei Li, Jiayue Xu, Chunrong Liu, Yongmei Lu, Kang Zou, Jing Tan, Xin Sun
  JAMA Network Open.2026; 9(2): e2558262.     CrossRef
• Association between pentoxifylline use and diabetic retinopathy in patients with type 2 diabetes mellitus and chronic kidney disease: A multi-institutional cohort study
  Tzu-Yi Lin, Eugene Yu-Chuan Kang, Nan-Kai Wang, Je-Ho Kang, Kuan-Jen Chen, Wei-Chi Wu, Chi-Chun Lai, Yih-Shiou Hwang
  Biomedical Journal.2025; 48(3): 100771.     CrossRef
• Impact of glucagon‐like peptide‐1 receptor agonists on diabetic retinopathy: A meta‐analysis of clinical studies emphasising retinal changes as a primary outcome
  Ishani Kapoor, Swara M. Sarvepalli, David A. D'Alessio, Majda Hadziahmetovic
  Clinical & Experimental Ophthalmology.2025; 53(1): 67.     CrossRef
• SGLT2 inhibitors and diabetic retinopathy: Insights from the management of nephropathy
  Maria S. Varughese, Lakshminarayanan Varadhan
  Eye.2025; 39(2): 213.     CrossRef
• Impact of Obstructive Sleep Apnea on Diabetic Retinopathy Progression and Systemic Complications
  Ehsan Rahimy, Euna B. Koo, Karen M. Wai, Cassie A. Ludwig, Andrea L. Kossler, Prithvi Mruthyunjaya
  American Journal of Ophthalmology.2025; 270: 93.     CrossRef
• An update on ocular effects of antidiabetic medications
  Elham Sadeghi, Elham Rahmanipour, Nicola Valsecchi, Saloni Kapoor, Maria Vittoria Cicinelli, Jay Chhablani
  Survey of Ophthalmology.2025; 70(4): 704.     CrossRef
• Glucagon-like peptide-1 receptor agonists and the eye
  David L. Zhang, Avni P. Finn
  Current Opinion in Ophthalmology.2025; 36(5): 407.     CrossRef
• Ocular outcomes of the sodium-glucose cotransport inhibitors: A systematic review of cohort studies
  Nathaniel Eraikhuemen, Bria George, Simon Leung, Shalonda Barnes Warren, Valerie Marcellus, Delany Santos Ferrer, Quovadis Epps
  Journal of Clinical Ophthalmology and Research.2025; 13(2): 220.     CrossRef
• Linear and non-linear association of chronic kidney disease with retina and choroid vessel density in diabetes: a prospective study
  Lijian Fang, Ruiheng Zhang, Suoqing Zhuang, Lei Wang, Qiuping Wang, Yong Huang, Mingli Wang, Yu Feng, Min Xiao, Chunyuan Zhou, Lili Wu, Sihan Zhang, Lili Xue, Tong Tian, Yuanyuan Li, Bing Cao, Huaiyu Hao
  Photodiagnosis and Photodynamic Therapy.2025; 53: 104625.     CrossRef
• Comparison of Sodium‐Glucose Cotransporter 2 Inhibitors Versus Glucagon‐Like Peptide‐1 Receptor Agonists and Risks of Osteoarthritis and Arthroplasty in Patients With Type 2 Diabetes Mellitus: A Propensity Score‐Matched Cohorts Retrospective Study
  Yu‐Chi Su, Pei‐Chun Hsieh, Edward Chia‐Cheng Lai, Yu‐Ching Lin
  Diabetes/Metabolism Research and Reviews.2025;[Epub]     CrossRef
• New generation agents for glycemic control and diabetic retinopathy progression: what we need to know?
  Stela Vujosevic, Caterina Toma, Anna Ferrulli, Stefano De Cillà, Paolo Nucci, Livio Luzi
  Acta Diabetologica.2025; 62(10): 1573.     CrossRef
• Sodium‐glucose co‐transporter 2 inhibitors reduce the intravitreal anti‐VEGF treatment necessity in eyes with early diabetic macular oedema: A post‐hoc analysis focusing on the fellow eye of the COMET trial
  Tomoaki Tatsumi, Yoko Takatsuna, Ryoichi Ishibashi, Masaya Koshizaka, Tomomi Kaiho, Toshiyuki Oshitari, Yuki Shiko, Noriko Asaumi, Shuichi Yamamoto, Koutaro Yokote, Takayuki Baba
  Diabetes, Obesity and Metabolism.2025; 27(10): 5812.     CrossRef
• Are GLP-1 receptor agonists and diabetic retinopathy foes or friends?
  Kai Liu, Shu Liu, Dong Wang, Hong Qiao
  Diabetes & Metabolism.2025; 51(6): 101696.     CrossRef
• Impact of SGLT2 inhibitors on the risk of age‐related ocular diseases in patients with type 2 diabetes mellitus: A target trial emulation study
  Yueh‐Tsung Lee, Jheng‐Yan Wu, Tsung W. Chang, Cheng‐Hsien Hung
  Diabetes, Obesity and Metabolism.2025; 27(12): 7299.     CrossRef
• Sodium-glucose cotransporter 2 inhibitors and risk of diabetic retinopathy: systematic review and meta-analysis
  Le Liang, Liping Yu, Yani He, Li Liu, Haohuan Yuan, Yating Hu, Jin Sun
  Canadian Journal of Ophthalmology.2025;[Epub]     CrossRef
• SGLT2 inhibitors for delaying diabetic retinopathy: a systematic review and meta-analysis
  Saba Goodarzi, Faezah Soltani Abhari, Gelareh Azarinoush, Mohammd Ali Rafiei, Hessam Yousefian, Ehsan Heidari, Edris Ekramipour, Afshin Mirzaei, Kosar Namakin, Arman Shafiee
  International Ophthalmology.2025;[Epub]     CrossRef
• Semaglutide and diabetic retinopathy: an OHDSI network study
  Cindy Xinji Cai, Akihiko Nishimura, Sally Baxter, Kerry Goetz, Michelle Hribar, Brian Toy, Andrew Barkmeier, Sophia Wang, Swarup Swaminathan, Alexis Flowers, Eric Brown, Benjamin Xu, John Chen, Aiyin Chen, Theodore Leng, Michael Boland, Thamir Alshammari,
  BMJ Open Diabetes Research & Care.2025; 13(6): e005424.     CrossRef
• Association of glucagon-like peptide-1 (GLP-1) receptor agonists and diabetic retinopathy (DR) – a systematic review and meta-analysis
  Hassan Alwafi, Sarah Saleh Al-Harbi, Ghada Ahmad Aladwani, Safaa M. Alsanosi, Tope Oyelade, Fahd Almalki, Husna Irfan Thalib, Abdallah Y. Naser, Manal Z. Alfahmi, Basil AlOtaibi, Samra Fuad, Mohammed Talha Mohammed Zubair, Abdulelah M. Aldhahir, Widya N.
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Glucagon-like peptide-1 receptor agonists: What ophthalmologists need to know
  Suraj Bala, Kevin C. Allan, Nicole L. Decker, Nadia J. Abbass, Julia H. Joo, Alison Zhao, Katherine E. Talcott, Aleksandra V. Rachitskaya
  Survey of Ophthalmology.2025;[Epub]     CrossRef
• Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies
  Samuel Igweokpala, Naheemot Olaoluwa Sule, Antonios Douros, Oriana H. Y. Yu, Kristian B. Filion
  Diabetes, Obesity and Metabolism.2024; 26(2): 721.     CrossRef
• Association of sodium–glucose cotransporter‐2 inhibitors and the risk of retinal vascular occlusion: A real‐world retrospective cohort study in Taiwan
  Tzu‐Yi Lin, Eugene Yu‐Chuan Kang, Shih‐Chieh Shao, Edward Chia‐Cheng Lai, Nan‐Kai Wang, Sunir J. Garg, Kuan‐Jen Chen, Je‐Ho Kang, Wei‐Chi Wu, Chi‐Chun Lai, Yih‐Shiou Hwang
  Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
• Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study
  Yu-Chi Su, Pei-Chun Hsieh, Edward Chia-Cheng Lai, Yu-Ching Lin
  Diabetes & Metabolism.2024; 50(2): 101522.     CrossRef
• Optimising renal risk parameters in type 2 diabetes mellitus: Perspectives from a retinal viewpoint
  Sarita Jacob, George I. Varughese
  Clinical Medicine.2024; 24(2): 100031.     CrossRef
• Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database
  Aikaterini Eleftheriadou, David Riley, Sizheng S. Zhao, Philip Austin, Gema Hernández, Gregory Y. H. Lip, Timothy L. Jackson, John P. H. Wilding, Uazman Alam
  Diabetologia.2024; 67(7): 1271.     CrossRef
• Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study
  Karen M. Wai, Kapil Mishra, Euna Koo, Cassie Ann Ludwig, Ravi Parikh, Prithvi Mruthyunjaya, Ehsan Rahimy
  American Journal of Ophthalmology.2024; 265: 39.     CrossRef
• Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy
  Andrew J. Barkmeier, Jeph Herrin, Kavya Sindhu Swarna, Yihong Deng, Eric C. Polley, Guillermo E. Umpierrez, Rodolfo J. Galindo, Joseph S. Ross, Mindy M. Mickelson, Rozalina G. McCoy
  Ophthalmology Retina.2024; 8(10): 943.     CrossRef
• Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis
  Bo Xu, Bo Kang, Fan Tang, Jiecan Zhou, Zunbo He
  Expert Review of Clinical Pharmacology.2024; 17(10): 949.     CrossRef
• Comparison of the Risk of Diabetic Retinopathy Between Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus in Japan: A Retrospective Analysis of Real-World Data
  Masaya Koshizaka, Tomoaki Tatsumi, Fumiko Kiyonaga, Yoshinori Kosakai, Yoko Yoshinaga, Mami Shintani-Tachi
  Diabetes Therapy.2024; 15(11): 2401.     CrossRef
• NOVEL AGENTS IN THE MANAGEMENT OF DIABETES AND RISK OF WORSENING DIABETIC RETINOPATHY
  Rithwick Rajagopal, Janet B. McGill
  Retina.2024; 44(11): 1851.     CrossRef
• Mechanism and therapeutic targets of circulating immune cells in diabetic retinopathy
  Bowen Zhao, Yin Zhao, Xufang Sun
  Pharmacological Research.2024; 210: 107505.     CrossRef
• Diabetes Renders Photoreceptors Susceptible to Retinal Ischemia-Reperfusion Injury
  David A. Antonetti, Cheng-Mao Lin, Sumathi Shanmugam, Heather Hager, Manjing Cao, Xuwen Liu, Alyssa Dreffs, Adam Habash, Steven F. Abcouwer
  Investigative Ophthalmology & Visual Science.2024; 65(13): 46.     CrossRef
• Multi-omics in exploring the pathophysiology of diabetic retinopathy
  Xinlu Li, XiaoJing Dong, Wen Zhang, Zhizhou Shi, Zhongjian Liu, Yalian Sa, Li Li, Ninghua Ni, Yan Mei
  Frontiers in Cell and Developmental Biology.2024;[Epub]     CrossRef
• Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
  Tzu-Yi Lin, Eugene Yu-Chuan Kang, Shih-Chieh Shao, Edward Chia-Cheng Lai, Yih-Shiou Hwang
  Diabetes & Metabolism Journal.2023; 47(4): 573.     CrossRef
• Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
  Jihee Ko, Sun Joon Moon
  Diabetes & Metabolism Journal.2023; 47(4): 571.     CrossRef
• Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinopathy in Patients With Type 2 Diabetes
  Fu-Shun Yen, James Cheng-Chung Wei, Teng-Shun Yu, Yu-Tung Hung, Chih-Cheng Hsu, Chii-Min Hwu
  JAMA Network Open.2023; 6(12): e2348431.     CrossRef

Citations

Citations to this article as recorded by  

• Innovative Diabetes Therapies and Impact on Peripheral and Autonomic Diabetic Neuropathies: A State-of-the-Art Review
  Jelena Vekic, Aleksandra Zeljkovic, Viviana Maggio, Manfredi Rizzo, Sanja Medenica
  Diabetes Therapy.2026;[Epub]     CrossRef
• Cardiac Autonomic Neuropathy in Diabetes Mellitus: Pathogenesis, Epidemiology, Diagnosis and Clinical Implications: A Narrative Review
  Alexandra Gogan, Ovidiu Potre, Vlad-Florian Avram, Minodora Andor, Florina Caruntu, Bogdan Timar
  Journal of Clinical Medicine.2025; 14(3): 671.     CrossRef
• Effect of the glucagon‐like peptide‐1 receptor agonists on diabetic peripheral neuropathy: A meta‐analysis
  Shujin Fan, Yue Qiu, Jing Liu, Tianxin Zhu, Chuan Wang, Dan Liu, Li Yan, Meng Ren
  Journal of Neurochemistry.2025;[Epub]     CrossRef
• Heart and health behavior responses to GLP-1 receptor agonists: a 12-wk study using wearable technology and causal inference
  Gregory J. Grosicki, Jeongeun Kim, Finn Fielding, Summer R. Jasinski, Christopher Chapman, William von Hippel, Kristen E. Holmes
  American Journal of Physiology-Heart and Circulatory Physiology.2025; 328(2): H235.     CrossRef
• The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort
  Eman A. Toraih, Awwad Alenezy, Mohammad H. Hussein, Shahmeer Hashmat, Saitej Mummadi, Nawaf Farhan Alrawili, Ahmed Abdelmaksoud, Manal S. Fawzy
  Biomedicines.2025; 13(5): 1049.     CrossRef
• Anorgasmia following initiation of GLP-1 agonist
  Vidya Visvabharathy, Sally MacPhedran, Katie Shupp, Benjamin King
  Sexual Medicine.2025;[Epub]     CrossRef
• Expanding the concept of pharma-cise: A graphical primer for clinicians, researchers and industry
  Ross Arena, Jonathan Myers, Nicolaas P. Pronk
  Current Problems in Cardiology.2025; 50(10): 103144.     CrossRef
• Cardiovascular effects of incretin-based drugs in patients with and without a history of heart failure: a protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials
  Mohammed El-Sheikh, Christina Dam Bjerregaard Sillassen, Frederik Dencker Wisborg, Jens Dahlgaard Hove, Carsten Dirksen, Matthew Meng Yang Lee, Janus C Jakobsen, Johannes Grand
  BMJ Open.2025; 15(9): e103668.     CrossRef
• Current Perspectives on GLP-1 Agonists in Contemporary Clinical Practice from Science and Mechanistic Foundations To Optimal Translation
  Husam Abu-Nejim, Richard C. Becker
  Current Atherosclerosis Reports.2025;[Epub]     CrossRef
• Genetic variation in the glucagon-like peptide-1 receptor protein encoding region is associated with higher heart rate variability, but not with neurodegeneration of the brain, retina, and peripheral nerves: The Maastricht study
  Frank C. T. van der Heide, Indra L. M. Steens, Archana Singh-Manoux, Séverine Sabia, Tan Lai Zhou, Sebastian Köhler, Miranda T. Schram, Carla J. H. van der Kallen, Tos T. J. M. Berendschot, Carroll A. B. Webers, Marleen M. J. van Greevenbroek, Anke Wessel
  Cardiovascular Diabetology.2025;[Epub]     CrossRef
• Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Mechanisms, Evidence and Identifying Optimal Candidates
  Magdy Abdelhamid, Mostafa M Abdrabou, Emanuel Faris, Sameh El Kafas, Mohamed Hosny, Ahmed Hassan
  Cardiac Failure Review.2025;[Epub]     CrossRef
• GLP-1 Receptor Agonists and Blood Pressure: A State-of-the-Art Review of Mechanisms, Evidence, and Clinical Implications
  Areesha Moiz, Tetiana Zolotarova, Kristian B Filion, Mark J Eisenberg
  American Journal of Hypertension.2025;[Epub]     CrossRef
• Liraglutide does not increase heart rate of diabetic patients during acute myocardial infarction
  Qianyi Li, Chunxuan Wu, Shiqun Sun, Lingchao Yang, Yanyan Li, Yixin Niu, Li Zhang, Wei Li, Ying Yu
  Journal of Diabetes.2024;[Epub]     CrossRef
• A randomized, double‐blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD‐JPN)
  Tomoaki Morioka, Masakazu Takeuchi, Akichika Ozeki, Masanori Emoto
  Diabetes, Obesity and Metabolism.2024; 26(8): 3167.     CrossRef
• Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management
  Aikaterini Eleftheriadou, Vincenza Spallone, Abd A. Tahrani, Uazman Alam
  Diabetologia.2024; 67(12): 2611.     CrossRef
• Autonomic Nervous System: A Therapeutic Target for Cardiac End-Organ Damage in Hypertension
  Lisa A. Gottlieb, Felix Mahfoud, Stavros Stavrakis, Thomas Jespersen, Dominik Linz
  Hypertension.2024; 81(10): 2027.     CrossRef
• Remodeling of the Intracardiac Ganglia During the Development of Cardiovascular Autonomic Dysfunction in Type 2 Diabetes: Molecular Mechanisms and Therapeutics
  Anthony J. Evans, Yu-Long Li
  International Journal of Molecular Sciences.2024; 25(22): 12464.     CrossRef
• Hormonal Gut–Brain Signaling for the Treatment of Obesity
  Eun Roh, Kyung Mook Choi
  International Journal of Molecular Sciences.2023; 24(4): 3384.     CrossRef
• Effects of new hypoglycemic drugs on cardiac remodeling: a systematic review and network meta-analysis
  Yi-lin Huang, Xiao-zhuo Xu, Jing Liu, Pin-yao Wang, Xue-li Wang, Hong-lin Feng, Cheng-jiang Liu, Xu Han
  BMC Cardiovascular Disorders.2023;[Epub]     CrossRef
• Obesity and hypertension: Obesity medicine association (OMA) clinical practice statement (CPS) 2023
  Tiffany Lowe Clayton, Angela Fitch, Harold Edward Bays
  Obesity Pillars.2023; 8: 100083.     CrossRef
• Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
  Jonathan Goldney, Jack A. Sargeant, Melanie J. Davies
  Diabetologia.2023; 66(10): 1832.     CrossRef
• Diabetes-Induced Cardiac Autonomic Neuropathy: Impact on Heart Function and Prognosis
  Susumu Z. Sudo, Tadeu L. Montagnoli, Bruna de S. Rocha, Aimeé D. Santos, Mauro P. L. de Sá, Gisele Zapata-Sudo
  Biomedicines.2022; 10(12): 3258.     CrossRef

Citations

Citations to this article as recorded by  

• Comparative Analysis of Clinical Outcomes in Patients With Type 2 Diabetes Mellitus on Monotherapy Versus Combination Therapy
  Hariballav Mahapatra, Piyush Kumar Gupta, Ajo Paul, Amit Nampalliwar, Manju Bansal, Baijnath Das, K. Parameswaran Namboothiri
  Cureus.2026;[Epub]     CrossRef
• Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique
  Carlos A. Yepes-Cortés, Isabel C. Cardenas-Moreno, Rodrigo Daza-Arnedo, Karen M. Feriz-Bonelo, Erica Yama-Mosquera, Alex H. Ramirez-Rincón, Gilberto A. Castillo-Barrios, Andres F. Suarez-Rodriguez, Johanna Carreño-Jiménez, Carlos E. Builes-Montaño
  Diabetes Therapy.2025; 16(5): 813.     CrossRef
• Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies
  Aftab Ahmad, Hani Sabbour
  Cardiovascular Diabetology.2024;[Epub]     CrossRef
• Sodium–Glucose Cotransporter Inhibitors: Cellular Mechanisms Involved in the Lipid Metabolism and the Treatment of Chronic Kidney Disease Associated with Metabolic Syndrome
  Fernando Cortés-Camacho, Oscar René Zambrano-Vásquez, Elena Aréchaga-Ocampo, Jorge Ismael Castañeda-Sánchez, José Guillermo Gonzaga-Sánchez, José Luis Sánchez-Gloria, Laura Gabriela Sánchez-Lozada, Horacio Osorio-Alonso
  Antioxidants.2024; 13(7): 768.     CrossRef
• SGLT2i and GLP1RA effects in patients followed in a hospital diabetology consultation
  António Cabral Lopes, Olga Lourenço, Manuel Morgado
  Expert Review of Clinical Pharmacology.2024; 17(11): 1081.     CrossRef
• Hormonal Gut–Brain Signaling for the Treatment of Obesity
  Eun Roh, Kyung Mook Choi
  International Journal of Molecular Sciences.2023; 24(4): 3384.     CrossRef
• All‐cause mortality and cardiovascular outcomes with sodium‐glucose Co‐transporter 2 inhibitors, glucagon‐like peptide‐1 receptor agonists and with combination therapy in people with type 2 diabetes
  David R. Riley, Hani Essa, Philip Austin, Frank Preston, Isatu Kargbo, Gema Hernández Ibarburu, Ramandeep Ghuman, Daniel J. Cuthbertson, Gregory Y. H. Lip, Uazman Alam
  Diabetes, Obesity and Metabolism.2023; 25(10): 2897.     CrossRef
• The Efficacy and Safety of the Combination Therapy With GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
  Chen Li, Jie Luo, Mingyan Jiang, Keke Wang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
  Hwi Seung Kim, Woo Je Lee
  Diabetes & Metabolism Journal.2022; 46(4): 665.     CrossRef
• Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
  Tomoyuki Kawada
  Diabetes & Metabolism Journal.2022; 46(4): 663.     CrossRef
• Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study
  Hwi Seung Kim, Yun Kyung Cho, Myung Jin Kim, Chang Hee Jung, Joong-Yeol Park, Woo Je Lee
  Frontiers in Endocrinology.2022;[Epub]     CrossRef

The burden of diabetic cardiovascular autonomic neuropathy (CAN) is expected to increase due to the diabetes epidemic and its early and widespread appearance. CAN has a definite prognostic role for mortality and cardiovascular morbidity. Putative mechanisms for this are tachycardia, QT interval prolongation, orthostatic hypotension, reverse dipping, and impaired heart rate variability, while emerging mechanisms like inflammation support the pervasiveness of autonomic dysfunction. Efforts to overcome CAN under-diagnosis are on the table: by promoting screening for symptoms and signs; by simplifying cardiovascular reflex tests; and by selecting the candidates for screening. CAN assessment allows for treatment of its manifestations, cardiovascular risk stratification, and tailoring therapeutic targets. Risk factors for CAN are mainly glycaemic control in type 1 diabetes mellitus (T1DM) and, in addition, hypertension, dyslipidaemia, and obesity in type 2 diabetes mellitus (T2DM), while preliminary data regard glycaemic variability, vitamin B12 and D changes, oxidative stress, inflammation, and genetic biomarkers. Glycaemic control prevents CAN in T1DM, whereas multifactorial intervention might be effective in T2DM. Lifestyle intervention improves autonomic function mostly in pre-diabetes. While there is no conclusive evidence for a disease-modifying therapy, treatment of CAN manifestations is available. The modulation of autonomic function by SGLT2i represents a promising research field with possible clinical relevance.

Citations

Citations to this article as recorded by  

• Impact of cardiovascular autonomic neuropathy on cardiopulmonary, sympathoadrenal and metabolic responses to physical exercise in adults with type 1 diabetes
  Olivia M. McCarthy, Rasmus B. Brødsgaard, Sandra Tawfik, Sissel Banner Lundemose, Emilie B. Lindkvist, Sara H. Naaman, Christian Stevns Hansen, Richard M. Bracken, Kirsten Nørgaard
  Diabetologia.2026; 69(3): 618.     CrossRef
• Echocardiographic insights into cardiovascular autonomic dysfunction in Parkinson's disease
  Zihao Li, Xiaohong Li, Wenlin Huang, Ziqi Gao, Piao Zhang, Chentao He, Siming Rong, Mengfei Cai, Zhenzhen Chen, Yan Li, Ruixue Xu, Lijuan Wang, Zhichao Zheng, Hongwen Fei, Yuhu Zhang
  Journal of Parkinson’s Disease.2026; 16(1): 146.     CrossRef
• Recent Advances in the Study of Diabetic Cardiac Autonomic Neuropathy
  Nan Wang, Jie Zhang
  Reviews in Cardiovascular Medicine.2026;[Epub]     CrossRef
• Cutoffs, sensitivity and specificity of the Ewing battery in evaluating autonomic nervous system disorders: a systematic review
  Theodora R. Barkoula, Christiana Ioannou, Martina Rekatsina, Kassiani Theodoraki, Panagiotis Zis
  Clinical Autonomic Research.2026;[Epub]     CrossRef
• Association between metabolic dysfunction-associated fatty liver disease and cardiovascular autonomic neuropathy in type 2 diabetes
  Rong Peng, Yaoyun Ao, Enni Cen, Junnian Chen, Zeshan Huang, Xiaoying Fu, Jian Kuang, Shuiqing Lai, Shuting Zhang
  Frontiers in Endocrinology.2026;[Epub]     CrossRef
• SDNN predicts 90-day disability after intravenous thrombolysis: autonomic dysfunction as a novel predictors in acute ischemic stroke
  Xiaoyan Wu, Jianping Wang, Liumeng Jian, Li Shi, Jie Li, Jianqiang Zhong, Guoyou Peng, Jianjun Guo
  Frontiers in Neurology.2026;[Epub]     CrossRef
• Normative data on measures of cardiovascular autonomic neuropathy and the effect of pretest conditions in a large Danish non-diabetic CVD-free population from the Lolland-Falster Health Study
  Christian S. Hansen, Marie Mathilde Bjerg Christensen, Dorte Vistisen, Randi Jepsen, Christina Ellervik, Marit Eika Jørgensen, Jesper Fleischer
  Clinical Autonomic Research.2025; 35(1): 101.     CrossRef
• Comparative study of autonomic function in diabetics and yoga practitioners using Ewing’s battery
  Tasneem Amadawala, Charushila Rukadikar, Dileep Deshpande
  Journal of Family Medicine and Primary Care.2025; 14(1): 121.     CrossRef
• A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?
  Stéphanie A. Eid, Kristy L. Townsend, Vincenza Spallone, Daniela M. Menichella, Emily J. Koubek, Eva L. Feldman
  Journal of the Peripheral Nervous System.2025;[Epub]     CrossRef
• Electrodiagnostic assessment of autonomic nervous system in diabetic autonomic neuropathy: Case series in 72 diabetes patients
  Suchitra Dube, Sandip M. Hulke, Santosh L. Wakode, Sagar Khadanga
  Journal of Family Medicine and Primary Care.2025; 14(1): 452.     CrossRef
• Disorders of circadian rhythms of heart rate variability in diabetic cardiac autonomic neuropathy: mechanisms and consequences
  V.A. Serhiyenko, M.I. Dolynay, V.B. Sehin, Y.V. Lazur, A.A. Serhiyenko
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2025; 20(8): 549.     CrossRef
• Cardiac Autonomic Neuropathy in Diabetes Mellitus: Pathogenesis, Epidemiology, Diagnosis and Clinical Implications: A Narrative Review
  Alexandra Gogan, Ovidiu Potre, Vlad-Florian Avram, Minodora Andor, Florina Caruntu, Bogdan Timar
  Journal of Clinical Medicine.2025; 14(3): 671.     CrossRef
• Cardiovascular autonomic neuropathy is associated with SLEDAI in patients with systemic lupus erythematosus
  Simin Guo, Yujiao Wang, Lingyun Sun
  Clinical Rheumatology.2025; 44(3): 1103.     CrossRef
• Correlation between Sirtuin 1 downregulation and reduced vitamin D receptor expression in patients with diabetic neuropathy
  Andrea Latini, Giada De Benedittis, Chiara Morgante, Beatrice Gasperini, Ilenia D’Ippolito, Davide Lauro, Giuseppe Novelli, Cinzia Ciccacci, Vincenza Spallone, Paola Borgiani
  Acta Diabetologica.2025; 62(9): 1395.     CrossRef
• Obesity Class and Severity of Metabolic Emergencies: A Single-Center Retrospective Five-Year Study
  Iulia Najette Crintea, Alexandru Cristian Cindrea, Teodor Florin Fulga, Cosmin Iosif Trebuian, Adina Maria Marza, Alina Petrica, Ovidiu Alexandru Mederle, Romulus Timar
  Healthcare.2025; 13(6): 617.     CrossRef
• Sequential classification approach for enhancing the assessment of cardiac autonomic neuropathy
  Moustafa Abdelwanis, Karim Moawad, Shahmir Mohammed, Ammar Hummieda, Shayaan Syed, Maher Maalouf, Herbert F. Jelinek
  Computers in Biology and Medicine.2025; 190: 109999.     CrossRef
• Pooled prevalence and associated factors of ECG abnormality among type 2 diabetic patients in the last ten years: Systematic review and meta-analysis
  Mihret Getnet, Habtu Kifle Negash, Hailu Aragie, Hiwot Tezera Endale, Tseganesh Asefa, Winta Tesfaye, Yibeltal Yismaw Gela, Gaetano Santulli
  PLOS ONE.2025; 20(3): e0319173.     CrossRef
• Resident Macrophages in the Cervical Sympathetic Ganglia Participate in P2Y12 Receptor Mediated Diabetic Cardiac Autonomic Neuropathy
  Junpei Du, Yuxin Yang, Jingan Rao, Xiaoqian Ma, Shanshan Tang, Jian Liu, Yeqing Liu, Shipan Liu, Guodong Li, Shangdong Liang, Yun Gao
  Molecular Neurobiology.2025; 62(8): 9744.     CrossRef
• Heart Rate Variability, Microvascular Dysfunction, and Inflammation: Exploring the Potential of taVNS in Managing Heart Failure in Type 2 Diabetes Mellitus
  Serge C. Thal, Sergey Shityakov, Ellaine Salvador, Carola Y. Förster
  Biomolecules.2025; 15(4): 499.     CrossRef
• Corneal confocal microscopy identifies early and definite diabetic cardiac autonomic neuropathy
  Shazli Azmi, Maryam Ferdousi, Alise Kalteniece, Ioannis N Petropoulos, Uazman Alam, Georgios Ponirakis, Omar Asghar, Andrew Marshall, Andrew JM Boulton, Nathan Efron, Rayaz A Malik
  Diabetes Research and Clinical Practice.2025; 224: 112172.     CrossRef
• Diabetic neuropathy: cutting-edge research and future directions
  Yang Yang, Bing Zhao, Yuanzhe Wang, Hongli Lan, Xinyu Liu, Yue Hu, Peng Cao
  Signal Transduction and Targeted Therapy.2025;[Epub]     CrossRef
• External validation of a clinical risk score for the presence of cardiovascular autonomic neuropathy in type 1 diabetes
  Pietro Pertile, Ilenia D'Ippolito, Beatrice De Santis, Aikaterini Andreadi, Davide Lauro, Vincenza Spallone
  Journal of Diabetes and its Complications.2025; 39(7): 109066.     CrossRef
• ВПЛИВ ВИМУШЕНОГО ПЕРЕСЕЛЕННЯ НА СТАН ХРОНІЧНОГО ЗАПАЛЕННЯ ТА ІНСУЛІНОВОЇ РЕЗИСТЕНТНОСТІ ПРИ ДІАБЕТИЧНІЙ КАРДІАЛЬНІЙ АВТОНОМНІЙ НЕЙРОПАТІЇ
  Вікторія Сергієнко, Володимир Сегін, Олександр Сергієнко
  PROBLEMS OF ENDOCRINE PATHOLOGY.2025; 82(1): 33.     CrossRef
• Features of short-term heart rate variability in internally displaced people with type 2 diabetes mellitus
  V.A. Serhiyenko, V.B. Sehin, V.I. Pankiv, A.A. Serhiyenko
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2025; 21(3): 243.     CrossRef
• Autonomic function and hemodynamic changes in type 2 diabetes: insights into sympathetic activation and vascular stiffness
  Larissa Morete Caieiro da Costa, Tatiana Palotta Minari, Luciana Pellegrini Pisani, Tatiane de Azevedo Rubio, Louise Bounalume Tácito Yugar, Luis Gustavo Sedenho-Prado, Milene Ribeiro, Lúcia Helena Bonalume Tacito, Luciana Neves Cosenso-Martin, Antônio Ca
  Diabetes Research and Clinical Practice.2025; 225: 112266.     CrossRef
• NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy
  Raffaele Galiero, Amel Rezki, Vittorio Simeon, Domenico Beccia, Maria Alfano, Alfredo Caturano, Ferdinando Carlo Sasso, Paul Valensi
  Journal of Diabetes and its Complications.2025; 39(9): 109107.     CrossRef
• High Diagnostic Performance of the Indicator Plaster Neuropad for the Detection of Established Diabetic Autonomic Neuropathy
  Ioanna Zografou, Panagiotis Doukelis, Theocharis Koufakis, Evangelia Kotzakioulafi, Polykarpos Evripidou, Zisis Kontoninas, Christos Savopoulos, Michael Doumas, Triantafyllos Didangelos, Konstantinos Kantartzis
  Diabetology.2025; 6(6): 55.     CrossRef
• 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association
  Shinae Kang, Seon Mee Kang, Jong Han Choi, Seung-Hyun Ko, Bo Kyung Koo, Hyuk-Sang Kwon, Mi Kyung Kim, Sang Yong Kim, Soo-Kyung Kim, Young-eun Kim, Eun Sook Kim, Jae Hyeon Kim, Chong Hwa Kim, Ji Min Kim, Hae Jin Kim, Min Kyong Moon, Sun Joon Moon, Jun Sung
  Diabetes & Metabolism Journal.2025; 49(4): 582.     CrossRef
• Cross-cultural adaptation and validation of the Ukrainian version of the Type 2 Diabetes Distress Assessment System
  V.A. Serhiyenkо, V.B. Sehin, S.Y. Holovach, A.A. Serhiyenko
  INTERNATIONAL NEUROLOGICAL JOURNAL.2025; 21(4): 266.     CrossRef
• Diabetic distress, low-grade chronic inflammation, and cardiac autonomic neuropathy in internally displaced people (literature review and own observations)
  V.A. Serhiyenkо
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2025; 21(4): 381.     CrossRef
• Initial Evaluation of Patients with Diabetes Mellitus according to Clinical Guidelines
  Dughyun Choi
  The Journal of Korean Diabetes.2025; 26(2): 69.     CrossRef
• Long-term prediction of mortality by heart rate turbulence in hemodialysis patients and the impact of diabetes mellitus–a longitudinal observational study
  Nora Hannane, Christopher C. Mayer, Julia Matschkal, Felix Bormann, Axel Krieter, Jürgen R. Braun, Claudius Küchle, Lutz Renders, Roman Günthner, Georg Schmidt, Alexander Müller, Siegfried Wassertheurer, Uwe Heemann, Bernhard Haller, Marek Malik, Christop
  Journal of Nephrology.2025; 38(8): 2261.     CrossRef
• Assessing the impact of supervised interval training on cardiovascular autonomic neuropathy in type 2 diabetes patients
  Laura Stirane, Karlis Stirans, Leonora Pahirko, Janis Mednieks, Karina Ostrovska, Aija Kļavina, Leo Selavo, Jelizaveta Sokolovska
  Physiological Reports.2025;[Epub]     CrossRef
• Glycaemic control, low levels of high-density lipoprotein, and high cardiovascular risk are associated with cardiovascular autonomic neuropathy
  Tina Okdahl, Anne-Marie Wegeberg, Marie Møller Jensen, Jonas Salling Quist, Christina Brock
  Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
• Obstructive Sleep Apnea and Type 2 Diabetes: An Update
  Sandro Gentile, Vincenzo Maria Monda, Giuseppina Guarino, Ersilia Satta, Maria Chiarello, Giuseppe Caccavale, Edi Mattera, Raffaele Marfella, Felice Strollo
  Journal of Clinical Medicine.2025; 14(15): 5574.     CrossRef
• Comparison of Diabetic Polyneuropathy and Cardiac Autonomic Neuropathy in Type 1 and Type 2 Diabetes Mellitus
  Laura Šiaulienė, Ieva Sereikė, Juozas Rimantas Lazutka, Joana Semigrejeviene, Žydrūnė Visockienė
  Diabetology.2025; 6(8): 74.     CrossRef
• Bioprospecting the antidiabetic potential of aqueous seed extract of Allanblackia floribunda Oliv. (Clusiaceae)
  John Alake, Wisdom Ahlidja, Isaac Tabiri Henneh, Augustine Kwabil, Kwabena Darko Adu, Samuel Ansong Asiamah, Du-Bois Asante, Francis Ackah Armah
  Food Chemistry Advances.2025; 8: 101071.     CrossRef
• Diabetes mellitus and postural hypotension in prehospital care
  William Young
  Journal of Paramedic Practice.2025; 17(9): 1.     CrossRef
• The prevalence of diabetic neuropathy in Greenland and its association with Inuit genetic ancestry – a cross-sectional study
  Marie Mathilde Bjerg Christensen, Christian Stevns Hansen, Jesper Fleischer, Ninna Senftleber, Frederik Filip Stæger, Torben Hansen, Daniel R. Witte, Marit Eika Jørgensen
  Journal of Diabetes and its Complications.2025; 39(11): 109179.     CrossRef
• Cardiac Autonomic Neuropathy and Its Impact on Progression of Diabetic Kidney Disease in Type 1 and Type 2 Diabetes
  Kywe Kywe Soe, Dinesh Selvarajah
  Kidney Medicine.2025; 7(12): 101149.     CrossRef
• SPARC-modified mesenchymal stem cells promote recovery of β-cells and insulin secretion by calcium ion homeostasis
  Jiaqi Gao, Balun Li, Hongkai Tian, Chenchen Li, Nikita Merzlikin, Dongyao Han, Zixi Ling, Zengyu Zhang, Wenlong zhu, Jianqi Dai, Lydmila Gerunova, Changrong Lv, Na Li, Jinlian Hua
  Stem Cell Research & Therapy.2025;[Epub]     CrossRef
• Association between physical activity propensity and cardiovascular autonomic neuropathy in type 1 diabetes: evidence from a single-centre study
  Simona Zaccaria, Laura Giurato, Isabella Nardone, Sium Wolde Sellasie, Innocenza Tripicchio, Marco Meloni, Pasquale Di Perna, Luigi Uccioli
  Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
• Physical Exercise Before Long‐Term Electrocardiogram May Enhance the Assessment of Nocturnal Heart Rate Variability in Young Individuals With Type 1 Diabetes Melltius
  Cecilia Fridolfsson, Peter Blomstrand, Jan Engvall, Johanna Thegerström
  Annals of Noninvasive Electrocardiology.2025;[Epub]     CrossRef
• Rectal sensitivity correlated with gastrointestinal‐mediated glucose disposal, but not the incretin effect
  Sondre Meling, Erling Tjora, Heike Eichele, Rasmus B. Nedergaard, Filip K. Knop, Niels Ejskjaer, Siri Carlsen, Pål R. Njølstad, Christina Brock, Eirik Søfteland
  Endocrinology, Diabetes & Metabolism.2024;[Epub]     CrossRef
• Glucose metabolism and autonomic function in healthy individuals and patients with type 2 diabetes mellitus at rest and during exercise
  Takuto Hamaoka, Urs A. Leuenberger, Rachel C. Drew, Matthew Murray, Cheryl Blaha, Jonathan Carter Luck, Lawrence I. Sinoway, Jian Cui
  Experimental Physiology.2024; 109(2): 214.     CrossRef
• Quantification of lipoproteins by proton nuclear magnetic resonance spectroscopy (1H-NMRS) improves the prediction of cardiac autonomic dysfunction in patients with type 1 diabetes
  L. Nattero-Chávez, M. Insenser, N. Amigó, S. Samino, N. Martínez-Micaelo, B. Dorado Avendaño, A. Quintero Tobar, H. F. Escobar-Morreale, M. Luque-Ramírez
  Journal of Endocrinological Investigation.2024; 47(8): 2075.     CrossRef
• Predictors of pacemaker requirement in patients with implantable loop recorder and unexplained syncope: A systematic review and meta‐analysis
  Moein Zangiabadian, Kiarash Soltani, Yasaman Gholinejad, Reyhane Yahya, Shayan Bastami, Mohammad Ali Akbarzadeh, Mohammad Sharifian Ardestani, Azadeh Aletaha
  Clinical Cardiology.2024;[Epub]     CrossRef
• Impaired Cardiovagal Activity as a Link Between Hyperglycemia and Arterial Stiffness in Adults With Type 2 Diabetes Mellitus Among an Eastern Indian Population: A Cross-sectional Study
  Nibedita Priyadarsini, Devineni Likhitha, Madumathy Ramachandran, Kishore Kumar Behera
  Canadian Journal of Diabetes.2024; 48(3): 147.     CrossRef
• No clear evidence of neuropathy among patients with high risk for the development of prediabetes/diabetes—a pilot study
  Anna E. Körei, Magdolna Békeffy, Adrienn Menyhárt, Karola Osgyán, Ildikó Istenes, Viktor J. Horváth, Péter Kempler
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Effects of Physical Cues on Stem Cell-Derived Extracellular Vesicles toward Neuropathy Applications
  Danyale Berry, Justice Ene, Aakash Nathani, Mandip Singh, Yan Li, Changchun Zeng
  Biomedicines.2024; 12(3): 489.     CrossRef
• Oxidative Stress, Endothelial Dysfunction, and N-Acetylcysteine in Type 2 Diabetes Mellitus
  Xin Li, Junyong Zou, Aiping Lin, Jingshu Chi, Hong Hao, Hong Chen, Zhenguo Liu
  Antioxidants & Redox Signaling.2024; 40(16-18): 968.     CrossRef
• High dose cholecalciferol supplementation causing morning blood pressure reduction in patients with type 1 diabetes mellitus and cardiovascular autonomic neuropathy
  João Felício, Lorena Moraes, Gabriela Lemos, Ícaro Souza, Giovana Vieira, Lilian Silva, Natércia Queiroz, Ana Carolina Souza, Franciane Melo, João Felício Abrahão Neto, Hana Britto, Manuela Lemos, Márcia Santos, Priscila Figueiredo, Ana Regina Motta, Meli
  Scientific Reports.2024;[Epub]     CrossRef
• Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial
  Ditte S. Kornum, Davide Bertoli, Huda Kufaishi, Anne-Marie Wegeberg, Tina Okdahl, Esben B. Mark, Katrine L. Høyer, Jens B. Frøkjær, Birgitte Brock, Klaus Krogh, Christian S. Hansen, Filip K. Knop, Christina Brock, Asbjørn M. Drewes
  Diabetologia.2024; 67(6): 1122.     CrossRef
• Independent and interactive associations of heart rate and obesity with type 2 diabetes mellites: A population‐based study
  Tianxin Zhu, Qingyu Chen, Hongxing Chen, Lili You, Dan Liu, Xiaoyun Zhang, Feng Li, Hongshi Wu, Juying Tang, Diaozhu Lin, Kan Sun, Li Yan, Meng Ren
  Journal of Diabetes.2024;[Epub]     CrossRef
• Bladder dysfunction in adolescents with type 1 diabetes
  Vinni Faber Rasmussen, Mathilde Thrysøe, Páll Karlsson, Mette Madsen, Esben Thyssen Vestergaard, Jens Randel Nyengaard, Astrid Juhl Terkelsen, Konstantinos Kamperis, Kurt Kristensen
  Journal of Pediatric Urology.2024; 20(4): 564.e1.     CrossRef
• Genetic markers of cardiac autonomic neuropathy in the Kazakh population
  Nazira Bekenova, Ainur Sibagatova, Alisher Aitkaliyev, Tamara Vochshenkova, Balzhan Kassiyeva, Valeriy Benberin
  BMC Cardiovascular Disorders.2024;[Epub]     CrossRef
• Acompanhamento e rastreamento de pacientes com Diabetes Mellitus Tipo 2 em uma unidade de saúde: prevenção de complicações macro e microvasculares
  Maria Helena Cordeiro de Oliveira, Milena Nunes Alves de Sousa
  Cuadernos de Educación y Desarrollo.2024; 16(5): e4145.     CrossRef
• POST-TRAUMATIC STRESS DISORDER, INSOMNIA, HEART RATE VARIABILITY AND METABOLIC SYNDROME (NARRATIVE REVIEW)
  Alexandr Serhiyenko, Myroslav Baitsar, Volodymyr Sehin, Ludmila Serhiyenko, Vitaliy Kuznets, Victoria Serhiyenko
  Proceeding of the Shevchenko Scientific Society. Medical Sciences.2024;[Epub]     CrossRef
• Determinants of Orthostatic Hypotension in Type 2 Diabetes: Is Cardiac Autonomic Neuropathy the Main Factor?
  Ilenia D'Ippolito, Myriam Angelica Carlucci, Cinzia D'Amato, Davide Lauro, Vincenza Spallone
  Endocrine Practice.2024; 30(9): 802.     CrossRef
• New Diabetic Treatment by Alleviation of Autonomic Nervous System Dysfunction Measured as Periosteal Pressure Sensitivity at Sternum Improves Empowerment, Treatment Satisfaction, and Self-Reported Health of People with Type 2 Diabetes: A Randomized Trial
  Sofie Hecquet, Søren Ballegaard, Ebbe Eldrup, Christian Hansen, Tine Hansen, Gitte Harboe, Peter Rossing, Caroline Pichat, Torquil Watt, Finn Gyntelberg, Nanna Ørsted, Jens Faber
  Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 2519.     CrossRef
• Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis
  Seyedeh Tarlan Mirzohreh, Padideh Panahi, Fariba Heidari
  Systematic Reviews.2024;[Epub]     CrossRef
• Predicting the dynamics of heart rate variability in patients with type 1 diabetes against improving glycemic control
  N.O. Pertseva, K.I. Moshenets
  Medicni perspektivi.2024; 29(2): 87.     CrossRef
• Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects
  Dario Ricciardi, Raffaele Galiero, Vincenzo Todisco, Gioacchino Tedeschi, Giuseppe Loffredo, Alfredo Caturano, Luca Rinaldi, Giovanni Cirillo, Ferdinando Carlo Sasso
  Metabolism and Target Organ Damage.2024;[Epub]     CrossRef
• Glycemic variability and diabetic cardiac autonomic neuropathy
  A.A. Serhiyenko, T.V. Tsaryk, Y.I. Pavlovskiy, V.A. Serhiyenko
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(4): 225.     CrossRef
• 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
  Jun Sung Moon, Shinae Kang, Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, Yoon Ju Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang
  Diabetes & Metabolism Journal.2024; 48(4): 546.     CrossRef
• Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management
  Aikaterini Eleftheriadou, Vincenza Spallone, Abd A. Tahrani, Uazman Alam
  Diabetologia.2024; 67(12): 2611.     CrossRef
• Prevalence of cardiovascular autonomic neuropathy in an admixed population of patients with type 1 diabetes. Lessons from a pioneer multicentre study in Brazil
  Lucianne Righeti Monteiro Tannus, Hermelinda Cordeiro Pedrosa, Cejana Hamu Aguiar, Karla Guerra Drummond, André Pinheiro, Franz Schubert Leal, Carlos Antonio Negrato, Marilia Brito Gomes
  Primary Care Diabetes.2024; 18(5): 539.     CrossRef
• Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
  Triantafyllos Didangelos, Eleni Karlafti, Evangelia Kotzakioulafi, Parthena Giannoulaki, Zisis Kontoninas, Anastasia Kontana, Polykarpos Evripidou, Christos Savopoulos, Andreas L. Birkenfeld, Konstantinos Kantartzis
  Nutrients.2024; 16(18): 3045.     CrossRef
• Cardiovascular Autonomic Dysfunction Before and After Chemotherapy in Cancer Patients
  So Young Yoon, Jeeyoung Oh
  Journal of Clinical Neurology.2024; 20(6): 551.     CrossRef
• Remodeling of the Intracardiac Ganglia During the Development of Cardiovascular Autonomic Dysfunction in Type 2 Diabetes: Molecular Mechanisms and Therapeutics
  Anthony J. Evans, Yu-Long Li
  International Journal of Molecular Sciences.2024; 25(22): 12464.     CrossRef
• Prevalence and Risk Factors of Cardiovascular Autonomic Neuropathy in Individuals with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  Xin Huang, Yun Bao, Jie Wang, Limin Tian
  Reviews in Cardiovascular Medicine.2024;[Epub]     CrossRef
• The impact of working night shifts on cardiac autonomic nervous regulation during the six-minute walk test in nurses
  Taihe Zhan, Xiumei Wei, Ziying Zhang, Zhimin Shi, Hongyan Xie, Xiaotao Ma, Suyue Pan, Daogang Zha
  BMC Nursing.2024;[Epub]     CrossRef
• D1S-Neuro Program: Frequency and Risk Factors for the Development of Diabetic Neuropathy in Pediatric Patients with Type 1 Diabetes Mellitus, a Single Center Study
  Marco Piccoli, Joaquin Gutierrez de Rubalcava Doblas, Patrizia Furlan, Silvia Cocchio, Alessandro Zamberlan, Gloria Panzeri, Vincenzo Baldo, Carlo Moretti
  Biomedicines.2024; 13(1): 19.     CrossRef
• Опитувальник «Композитна оцінка вегетативних симптомів 31» (COMPASS 31): валідація та можливості застосування в діагностиці вегетативної дисфункції у хворих на цукровий діабет 2-го типу
  V.A. Serhiyenko, V.B. Sehin, A.A.
  Endokrynologia.2024; 29(4): 338.     CrossRef
• Mortality risk factors in newly diagnosed diabetic cardiac autonomic neuropathy
  Bruce A. Chase, Sylwia Pocica, Roberta Frigerio, Katerina Markopoulou, Demetrius M. Maraganore, Navamon Aunaetitrakul, Alexander Epshteyn, Alexandru C. Barboi
  Clinical Autonomic Research.2023; 33(6): 903.     CrossRef
• Autonomic symptoms and associated factors in patients with chronic heart failure
  Hellen Da Silva, Sofie Pardaens, Marc Vanderheyden, Johan De Sutter, Heleen Demeyer, Michel De Pauw, Laurent Demulier, Jan Stautemas, Patrick Calders
  Acta Cardiologica.2023; 78(2): 203.     CrossRef
• Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
  Jonathan Goldney, Jack A. Sargeant, Melanie J. Davies
  Diabetologia.2023; 66(10): 1832.     CrossRef
• Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings
  Eleonora Galosi, Luca Leonardi, Pietro Falco, Giuseppe Di Pietro, Alessandra Fasolino, Nicoletta Esposito, Caterina Leone, Giulia Di Stefano, Maurizio Inghilleri, Marco Luigetti, Antonini Giovanni, Andrea Truini
  Amyloid.2023; 30(1): 59.     CrossRef
• In vivo molecular imaging of cardiac angiogenesis in persons with and without type 2 diabetes: A cross‐sectional 68 Ga‐RGD‐PET study
  Jens Christian Laursen, Ida Kirstine Bull Rasmussen, Emilie Hein Zobel, Philip Hasbak, Lene Holmvang, Christian Stevns Hansen, Bernt Johan von Scholten, Marie Frimodt‐Møller, Peter Rossing, Tine Willum Hansen, Andreas Kjaer, Rasmus Sejersten Ripa
  Diabetic Medicine.2023;[Epub]     CrossRef
• Cardiac innervations in diabetes mellitus—Anatomical evidence of neuropathy
  Natalija Filipović, Maja Marinović Guić, Vana Košta, Katarina Vukojević
  The Anatomical Record.2023; 306(9): 2345.     CrossRef
• Clinical Predictors of Pacing Device Implantation in Implantable Cardiac Monitor Recipients for Unexplained Syncope
  Reina Tonegawa-Kuji, Yuko Y. Inoue, Michikazu Nakai, Koshiro Kanaoka, Yoko Sumita, Yuichiro Miyazaki, Akinori Wakamiya, Keiko Shimamoto, Nobuhiko Ueda, Kenzaburo Nakajima, Naoya Kataoka, Mitsuru Wada, Kenichiro Yamagata, Kohei Ishibashi, Koji Miyamoto, Sa
  CJC Open.2023; 5(4): 259.     CrossRef
• Cardiovascular autonomic reflex tests using a handheld device in the diagnosis of cardiovascular autonomic neuropathy in patients with schizophrenia
  Laura Blok-Husum, Milka Ane Rank Brcelic, Hanin Kawa Farman Kawal Bassi, Svend Eggert Jensen, Rene Ernst Nielsen, Kristian Kragholm, Jesper Fleischer, Esben Laugesen, Christoffer Polcwiartek
  American Heart Journal Plus: Cardiology Research and Practice.2023; 26: 100252.     CrossRef
• Causal association between vitamin D and diabetic neuropathy: a Mendelian randomization analysis
  Wei Huang, Lei Gu, Jingwen Wang, Yiqi Wang, Fangzheng Cao, Tianyu Jin, Yifan Cheng
  Endocrine.2023; 80(2): 328.     CrossRef
• Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
  Panagiotis Theofilis, Evangelos Oikonomou, Konstantinos Tsioufis, Dimitris Tousoulis
  Life.2023; 13(2): 497.     CrossRef
• Sex differences and sex steroids influence on the presentation and severity of cardiovascular autonomic neuropathy of patients with type 1 diabetes
  Lía Nattero-Chávez, María Insenser, Alejandra Quintero Tobar, Elena Fernández-Durán, Beatriz Dorado Avendaño, Tom Fiers, Jean-Marc Kaufman, Manuel Luque-Ramírez, Héctor F. Escobar-Morreale
  Cardiovascular Diabetology.2023;[Epub]     CrossRef
• Early Gastrointestinal Neuropathy Assessed by Wireless Motility Capsules in Adolescents with Type 1 Diabetes
  Vinni Faber Rasmussen, Mathilde Thrysøe, Páll Karlsson, Esben Thyssen Vestergaard, Kurt Kristensen, Ann-Margrethe Rønholt Christensen, Jens Randel Nyengaard, Astrid Juhl Terkelsen, Christina Brock, Klaus Krogh
  Journal of Clinical Medicine.2023; 12(5): 1925.     CrossRef
• Heart rate variability in people with metabolic syndrome
  Kostiantyn Apykhtin, Svitlana Drozdovska, Olha Hurenko, Anastasiia Nahorna, Anatoly Pisaruk, Yuliia Panchenko, Olena Andrieieva
  Ageing and Longevity.2023; 4(1): 1.     CrossRef
• Heart rate variability in people with metabolic syndrome
  Kostiantyn Apykhtin, Svitlana Drozdovska, Olha Hurenko, Anastasiia Nahorna, Anatoly Pisaruk, Yuliia Panchenko, Olena Andrieieva
  JOURNAL OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE.2023; (1 2023): 1.     CrossRef
• Potential of electronic devices for detection of health problems in older adults at home: A systematic review and meta-analysis
  Yu-ting Cao, Xin-xin Zhao, Yi-ting Yang, Shi-jie Zhu, Liang-dong Zheng, Ting Ying, Zhou Sha, Rui Zhu, Tao Wu
  Geriatric Nursing.2023; 51: 54.     CrossRef
• Diabetes mellitus in der Akut- und Notfallmedizin
  Leo Benning, Julian Krehl, Felix Patricius Hans
  Notfallmedizin up2date.2023; 18(01): 45.     CrossRef
• Correlation between Heart rate recovery and Left Atrial phasic functions evaluated by 2D speckle-tracking Echocardiography after Acute Myocardial infarction
  Behruz Mashayekhi, Reza Mohseni-Badalabadi, Ali Hosseinsabet, Tahereh Ahmadian
  BMC Cardiovascular Disorders.2023;[Epub]     CrossRef
• Pancreatic sympathetic innervation disturbance in type 1 diabetes
  Senlin Li, Huimin Yuan, Keshan Yang, Qing Li, Ming Xiang
  Clinical Immunology.2023; 250: 109319.     CrossRef
• A Nonrandomized Trial of the Effects of Passive Simulated Jogging on Short-Term Heart Rate Variability in Type 2 Diabetic Subjects
  Jose A. Adams, Jose R. Lopez, Veronica Banderas, Marvin A. Sackner, Mark Yorek
  Journal of Diabetes Research.2023; 2023: 1.     CrossRef
• Evaluating treatment options for cardiovascular autonomic neuropathy in patients with diabetes mellitus: a systematic review
  Jasmine KaiLi Goh, Leroy Koh
  Diabetology International.2023; 14(3): 224.     CrossRef
• Autonomic neuropathic symptoms in patients with diabetes: practical tools for screening in daily routine
  Ana Raquel Souza de Azevedo Vieira, Lara Benigno Porto-Dantas, Flaviene Alves do Prado Romani, Patrícia Souza Carvalho, Rodica Pop-Busui, Hermelinda Cordeiro Pedrosa
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• “Arterial stiffness is not associated with changes in the circadian pattern of blood pressure in patients with type 1 diabetes mellitus and cardiovascular autonomic dysfunction”
  Lía Nattero-Chávez, Ane Bayona Cebada, Elena Fernández-Durán, Alejandra Quintero Tobar, Beatriz Dorado Avendaño, Héctor Escobar-Morreale, Manuel Luque-Ramírez
  Diabetes and Vascular Disease Research.2023;[Epub]     CrossRef
• Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN)
  Sanjeev Sharma, Gerry Rayman
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• In Type 2 Diabetes Mellitus, normalization of hemoglobin A1c accompanies reduced sensitivity to pressure at the sternum
  Jens Faber, Søren Ballegaard, Nanna Ørsted, Ebbe Eldrup, Benny Karpatschof, Finn Gyntelberg, Sofie Korsgaard Hecquet, Albert Gjedde
  Frontiers in Neuroscience.2023;[Epub]     CrossRef
• Functional status associated with postural dizziness, but not postural hypotension, in older adults: a community-based study
  Hsiang-Ju Cheng, Zih-Jie Sun, Feng-Hwa Lu, Yi-Ching Yang, Chih-Jen Chang, Jin-Shang Wu
  BMC Geriatrics.2023;[Epub]     CrossRef
• Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open‐label, crossover trial
  Jens Christian Laursen, Viktor Rotbain Curovic, Marjolein Y. A. M. Kroonen, Niels Jongs, Emilie H. Zobel, Tine W. Hansen, Marie Frimodt‐Møller, Gozewijn D. Laverman, Adriaan Kooy, Frederik Persson, Hiddo J. L. Heerspink, Christian Stevns Hansen, Peter Ros
  Diabetes, Obesity and Metabolism.2023; 25(10): 3064.     CrossRef
• The Retinal Nerve Fiber Layer Thickness Is Associated with Systemic Neurodegeneration in Long-Term Type 1 Diabetes
  Christina Brock, Anne-Marie Wegeberg, Thomas Arendt Nielsen, Bassam Karout, Per M. Hellström, Asbjørn Mohr Drewes, Henrik Vorum
  Translational Vision Science & Technology.2023; 12(6): 23.     CrossRef
• The Use of Empirical Mode Decomposition on Heart Rate Variability Signals to Assess Autonomic Neuropathy Progression in Type 2 Diabetes
  Sandra Cossul, Felipe Rettore Andreis, Mateus Andre Favretto, Jefferson Luiz Brum Marques
  Applied Sciences.2023; 13(13): 7824.     CrossRef
• Topical Capsaicin for the Management of Painful Diabetic Neuropathy: A Narrative Systematic Review
  Brandon Goodwin, Maanas Chiplunkar, Ryan Salerno, Kylon Coombs, Umar Sannoh, Vrushank Shah, Nicholas Averell, Usmaan Al-Shebab, Deanna Janora
  Pain Management.2023; 13(5): 309.     CrossRef
• Adynamic response to cold pain reflects dysautonomia in type 1 diabetes and polyneuropathy
  Thomas Arendt Nielsen, Søren Lundbye-Christensen, Yoanna Krasimirova Dimitrova, Sam Riahi, Birgitte Brock, Asbjørn Mohr Drewes, Christina Brock
  Scientific Reports.2023;[Epub]     CrossRef
• Autonomic Nerve Function Tests in Patients with Diabetes
  Heung Yong Jin, Tae Sun Park
  The Journal of Korean Diabetes.2023; 24(2): 71.     CrossRef
• Understanding the role of hyperglycemia and the molecular mechanism associated with diabetic neuropathy and possible therapeutic strategies
  Mandeep Kaur, Sakshi Misra, Priyanka Swarnkar, Preeti Patel, Balak Das Kurmi, Ghanshyam Das Gupta, Amrita Singh
  Biochemical Pharmacology.2023; 215: 115723.     CrossRef
• A three-month physical training program improves cardiovascular autonomic function in patients with metabolic syndrome with and without diabetes – a pilot study
  Anna Vágvölgyi, Judit Erzsébet Ábrahám, Éva Máthéné Köteles, Andrea Korom, Mária Barnai, Mónika Szűcs, Andrea Orosz, Péter Kempler, Adrienn Menyhárt, Attila Nemes, Tamás Várkonyi, István Baczkó, István Kósa, Csaba Lengyel
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Cardiovascular autonomic neuropathy in patients with type 2 diabetes with and without sensorimotor polyneuropathy
  Emil Peters, Mustapha Itani, Alexander G. Kristensen, Astrid Juhl Terkelsen, Thomas Krøigård, Hatice Tankisi, Troels S. Jensen, Nanna B. Finnerup, Sandra Sif Gylfadottir
  Journal of the Peripheral Nervous System.2023; 28(3): 450.     CrossRef
• Cardiac Autonomic Neuropathy in Prediabetes: A Case-Control Study
  Pavan Gujjar, Y. S. Ravikumar, Lakshmi Nagendra, Hiya Boro, Saptarshi Bhattacharya
  Indian Journal of Endocrinology and Metabolism.2023; 27(4): 325.     CrossRef
• Diabetic Neuropathies
  Melissa A. Elafros, Brian C. Callaghan
  Continuum.2023; 29(5): 1401.     CrossRef
• Determinants of the heart rate variability in type 1 diabetes mellitus
  Máté Hajdu, Konstandia Garmpis, Vivien Vértes, Noémi Vorobcsuk-Varga, Gergő Attila Molnár, László Hejjel, István Wittmann, Réka Faludi
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• The Effect of Exercise on Cardiovascular Autonomic Nervous Function in Patients with Diabetes: A Systematic Review
  Hidetaka Hamasaki
  Healthcare.2023; 11(19): 2668.     CrossRef
• Influence of Fibrinogen/Albumin Ratio and Fibrinogen/Pre-Albumin Ratio on Cardiac Autonomic Neuropathy in Type 2 Diabetes
  Subei Zhao, Zheng Yang, Meng Yu, Linyu Xiang, Yuhuan Lv, Chunyan Tian, Rong Li
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 3249.     CrossRef
• In Ischemic Heart Disease, Reduced Sensitivity to Pressure at the Sternum Accompanies Lower Mortality after Five Years: Evidence from a Randomized Controlled Trial
  Søren Ballegaard, Jens Faber, Christian Selmer, Finn Gyntelberg, Svend Kreiner, Benny Karpatschof, Tobias Wirenfeldt Klausen, Åke Hjalmarson, Albert Gjedde
  Journal of Clinical Medicine.2023; 12(24): 7585.     CrossRef
• Assessment of the relationship of systemic vascular dysfunction and cardiac autonomic neuropathy (CAN) with diabetic retinopathy
  KJ Hari Prakash, Sucheta Parija, Manisha Kar
  Journal of Family Medicine and Primary Care.2023; 12(12): 3236.     CrossRef
• Autonomic Neuropathy in Ambulatory Type 2 Diabetes Mellitus Patients: A Single-arm Prospective, Observational Study
  Kaustav Saha, Shatavisa Mukherjee, Animesh Maiti, Santanu Kumar Tripathi
  Journal of the Practice of Cardiovascular Sciences.2023; 9(3): 178.     CrossRef
• Insomnia and type 2 diabetes: how to help the patient. Modern view of a neurologist
  E. S. Akarachkova, O. V. Kotova, V. L. Klimov, D. I. Lebedeva
  FOCUS. Endocrinology.2023; 4(4): 12.     CrossRef
• Carvedilol improves heart rate variability indices, biomarkers but not cardiac nerve density in streptozotocin-induced T2DM model of diabetic cardiac autonomic neuropathy
  Olawale Mathias Akinlade, Bamidele Owoyele, Olufemi Ayodele Soladoye
  Journal of Basic and Clinical Physiology and Pharmacology.2022; 33(2): 213.     CrossRef
• Cardiovascular autonomic responses during head-up tilt test in newly diagnosed type 2 diabetes
  Esteban Jorge-Galarza, Margarita Torres-Tamayo, María del Rocío Martínez-Alvarado, Berenice Peña-Aparicio, Carmen González-Salazar, Juan Reyes-Barrera, Manuel Sierra-Beltrán, Erika Fajardo-Flores, Andrey Kostin, J. Antonio González-Hermosillo
  Irish Journal of Medical Science (1971 -).2022; 191(5): 2077.     CrossRef
• Cardiovascular autonomic neuropathy and incident diabetic kidney disease in patients with type 2 diabetes
  Ji Eun Jun, Min Sun Choi, Jae Hyeon Kim
  Diabetes Research and Clinical Practice.2022; 184: 109181.     CrossRef
• Kardiovaskuläre Risiken in der 4.–6. Lebensdekade mit Diabetes mellitus Typ 1
  Young Hee Lee-Barkey, Bernd Stratmann, Diethelm Tschöpe
  Der Diabetologe.2022; 18(2): 131.     CrossRef
• Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants
  Francesca Romana Prandi, Isabella Evangelista, Domenico Sergi, Alberto Palazzuoli, Francesco Romeo
  Heart Failure Reviews.2022; 28(3): 597.     CrossRef
• Comparison of Risk Assessment Strategies for Patients with Diabetes Mellitus and Stable Chest Pain: A Coronary Computed Tomography Angiography Study
  Jia Zhao, Shuo Wang, Pengyu Zhao, Yong Huo, Chunjie Li, Jia Zhou, Pawel Kleczynski
  Journal of Diabetes Research.2022; 2022: 1.     CrossRef
• BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy
  Gidon J Bönhof, Gundega Sipola, Alexander Strom, Christian Herder, Klaus Strassburger, Birgit Knebel, Claudia Reule, Jan-Christoph Wollmann, Andrea Icks, Hadi Al-Hasani, Michael Roden, Oliver Kuss, Dan Ziegler
  BMJ Open.2022; 12(2): e057142.     CrossRef
• Pragmatic Clinic-Based Investigation of Glycemic Variability in Patients With Type 1 Diabetes in Routine Clinical Practice and Its Association With Cardiovascular Autonomic Neuropathy: A Pilot Study
  Lucianne R.M. Tannus, Marilia B. Gomes
  Endocrine Practice.2022; 28(5): 465.     CrossRef
• Longitudinal effects of one‐leg standing time on neuropathy outcomes in association with glycemic control in non‐elderly patients with type 2 diabetes
  Kazuhiro Sugimoto, Takashi Sozu, Takehiko Hoshino, Yuko Watanabe, Akira Tamura, Toshiro Yamazaki, Setsu Ohta, Susumu Suzuki, Takuro Shimbo
  Journal of Diabetes Investigation.2022; 13(6): 1039.     CrossRef
• Thermal quantitative sensory testing as a screening tool for cardiac autonomic neuropathy in patients with diabetes mellitus
  Veronika Potockova, Sarka Mala, Lucie Hoskovcova, Vaclav Capek, Tomas Nedelka, Lucie Riedlbauchova, Daniel Baumgartner, Livie Mensova, Radim Mazanec
  Brain and Behavior.2022;[Epub]     CrossRef
• Cardiovascular Autonomic Reflex Tests and 7 Heart Rate Variability Indices for Early Diagnosis of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Individuals
  Yeelen Ballesteros Atala, Mozânia Reis De Matos, Denise Engelbrecht Zantut-Wittmann, Alejandro Rosell Castillo, Daniele P Santos-Bezerra, Maria Lucia Correa-Giannella, Maria Cândida Ribeiro Parisi
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Design, synthesis, in vitro and in silico studies of naproxen derivatives as dual lipoxygenase and α-glucosidase inhibitors
  Asma Sardar, Obaid-ur-Rahman Abid, Saima Daud, M. Fakhar-e-Alam, Muhammad Hussnain Siddique, Muhammad Ashraf, Wardah Shahid, Syeda Abida Ejaz, M. Atif, Shafiq Ahmad, Sulman Shafeeq, Muhammad Afzal
  Journal of Saudi Chemical Society.2022; 26(3): 101468.     CrossRef
• Clinical manifestations and evaluation of cardiac autonomic neuropathy in diabetes mellitus and metabolic syndrome
  L. S. Moshkhoeva, A. N. Barinov
  Neurology, Neuropsychiatry, Psychosomatics.2022; 14(2): 71.     CrossRef
• The relationship between vitamin B12 levels and electrocardiographic ventricular repolarization markers
  Emre Yılmaz, Devrim Kurt, Aslı Vural, Ertan Aydın, Sencer Çamcı, Ercan Aydın
  Nutrición Hospitalaria.2022;[Epub]     CrossRef
• The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double‐blinded, placebo‐controlled trial
  Suvanjaa Sivalingam, Emilie Hein Zobel, Christian S. Hansen, Rasmus S. Ripa, Bernt J. von Scholten, Viktor Rotbain Curovic, Andreas Kjaer, Jacob K. Jensen, Tine W. Hansen, Peter Rossing
  Diabetes, Obesity and Metabolism.2022; 24(8): 1638.     CrossRef
• Heart Rate Variability and Chronic Kidney Disease in Patients with Type 2 Diabetes
  Wei Shi, Jing Zhang, Dan Chen, Xiaolei Chen, Wei Duan, Hongmei Zhang, Fahd Abd Algalil
  Applied Bionics and Biomechanics.2022; 2022: 1.     CrossRef
• Spectrum of Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus
  Prativa Priyadarshani Sethi, Basavraj Jatteppanavar, Ravi Kant, Monika Pathania, Mukesh Chand Bairwa
  Journal of Cardio-diabetes and Metabolic Disorders.2022; 2(1): 23.     CrossRef
• Cardiac Autonomic Dysfunction Is Associated With Risk of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus
  Haixia Zeng, Jianmo Liu, Zheng Chen, Peng Yu, Jianping Liu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy and Cardiovascular Autonomic Neuropathy
  Gidon J. Bönhof, Christian Herder, Dan Ziegler
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Triglyceride glucose index is related with cardiac autonomic dysfunction in patients with metabolic syndrome
  Akif Serhat Balcıoğlu, Ekrem Aksu, Ahmet Çağrı Aykan
  Kardiologiia.2022; 62(6): 45.     CrossRef
• Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes
  Sasha Smith, Pasha Normahani, Tristan Lane, David Hohenschurz-Schmidt, Nick Oliver, Alun Huw Davies
  Life.2022; 12(7): 1074.     CrossRef
• Correlation between impaired hemodynamic response and cardiopulmonary fitness in middle-aged type 2 diabetes mellitus patients: a case–control study
  Jinjin Xie, Lianhua Yin, Jia Huang, Ying Xu, Yannan Chen, Jiawei Qin, Zhizhen Liu, Jing Tao
  European Journal of Applied Physiology.2022; 122(10): 2295.     CrossRef
• Higher frequency of cardiovascular autonomic neuropathy in youth with type 2 compared to type 1 diabetes: Role of cardiometabolic risk factors
  Benjamin J. Varley, Megan L. Gow, Yoon Hi Cho, Paul Benitez‐Aguirre, Janine Cusumano, Alison Pryke, Albert Chan, Vallimayil Velayutham, Kim C. Donaghue, Maria E. Craig
  Pediatric Diabetes.2022; 23(7): 1073.     CrossRef
• The role of protein kinase C in diabetic microvascular complications
  Deng Pan, Lin Xu, Ming Guo
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Effect of SGLT-2 inhibitors on cardiac autonomic function in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
  Dimitrios Patoulias, Alexandra Katsimardou, Nikolaos Fragakis, Christodoulos Papadopoulos, Michael Doumas
  Acta Diabetologica.2022; 60(1): 1.     CrossRef
• Association between blood glucose levels and autonomic symptoms in Peru
  Gabriel Angeles-Zurita, Margorie Narro-Fuentes, Antonio Bernabe-Ortiz
  Primary Care Diabetes.2022; 16(5): 709.     CrossRef
• Clinical scoring systems for the risk of cardiovascular autonomic neuropathy in type 1 and type 2 diabetes: A simple tool
  Marika Menduni, Cinzia D'Amato, Martina Leoni, Valentina Izzo, Mariateresa Staltari, Carla Greco, Andrea Abbatepassero, Giuseppe Seminara, Ilenia D'Ippolito, Davide Lauro, Vincenza Spallone
  Journal of the Peripheral Nervous System.2022; 27(4): 259.     CrossRef
• Vagus nerve stimulation as a novel treatment for systemic lupus erythematous: study protocol for a randomised, parallel-group, sham-controlled investigator-initiated clinical trial, the SLE-VNS study
  Amanda Hempel Zinglersen, Ida Lynghøj Drange, Katrine Aagaard Myhr, Andreas Fuchs, Mogens Pfeiffer-Jensen, Christina Brock, Søren Jacobsen
  BMJ Open.2022; 12(9): e064552.     CrossRef
• To the interpretation of frequency components of the heart rate variability
  N. V. Kuzmenko, V. A. Tsyrlin, M. G. Pliss
  Translational Medicine.2022; 9(3): 35.     CrossRef
• Protein pyrrole adducts are associated with elevated glucose indices and clinical features of diabetic diffuse neuropathies
  Xiao Chen, Zhuyi Jiang, Lianjing Zhang, Wei Liu, Xiaohu Ren, Luling Nie, Desheng Wu, Zhiwei Guo, Weimin Liu, Xifei Yang, Yan Wu, Zhen Liang, Peter Spencer, Jianjun Liu
  Journal of Diabetes.2022; 14(10): 646.     CrossRef
• Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management
  Scott Williams, Siddig Abdel Raheim, Muhammad Ilyas Khan, Umme Rubab, Prathap Kanagala, Sizheng Steven Zhao, Anne Marshall, Emily Brown, Uazman Alam
  Clinical Therapeutics.2022; 44(10): 1394.     CrossRef
• Pathophysiological and clinical aspects of the circadian rhythm of arterial stiffness in diabetes mellitus: A minireview
  Victoria A. Serhiyenko, Ludmila M. Serhiyenko, Volodymyr B. Sehin, Alexandr A. Serhiyenko
  Endocrine Regulations.2022; 56(4): 284.     CrossRef
• Heart rate-corrected QT interval prolongation is associated with decreased heart rate variability in patients with type 2 diabetes
  Seon-Ah Cha
  Medicine.2022; 101(45): e31511.     CrossRef
• Effect of the Glucagon-Like Peptide-1 Receptor Agonists on Autonomic Function in Subjects with Diabetes: A Systematic Review and Meta-Analysis
  Carla Greco, Daniele Santi, Giulia Brigante, Chiara Pacchioni, Manuela Simoni
  Diabetes & Metabolism Journal.2022; 46(6): 901.     CrossRef
• Diabetes-Induced Cardiac Autonomic Neuropathy: Impact on Heart Function and Prognosis
  Susumu Z. Sudo, Tadeu L. Montagnoli, Bruna de S. Rocha, Aimeé D. Santos, Mauro P. L. de Sá, Gisele Zapata-Sudo
  Biomedicines.2022; 10(12): 3258.     CrossRef
• The Relationship Between Orthostatic Hypotension and Vitamin D Deficiency in Patients with Uncontrolled Type 2 Diabetes Mellitus
  Ece YİĞİT, Ridvan SİVRİTEPE, Dilay KARABULUT, Umut KARABULUT
  Online Türk Sağlık Bilimleri Dergisi.2022; 7(2): 313.     CrossRef
• A study of heart rate variability in diabetic mellitus patients
  Srinivasa Jayachandra, Satyanath Reddy Kodidala
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(3): 153.     CrossRef
• Oxidative Damage and Anti-Inflammatory Activity of Myricetin from Berries in Streptozotocin-Induced Diabetic Rats
  Shuling Wang, Jing Zhang
  International Journal of Pharmacology.2022; 18(4): 753.     CrossRef
• Validation and Comparison of PROMISE and CONFIRM Model to Predict High-Risk Coronary Artery Disease in Symptomatic and Diabetes Mellitus Patients
  Hantao Jiang, Jinping Feng, Chao Feng, Pei Ren, Kai Ren, Ying Jin, Jia Zhou
  Reviews in Cardiovascular Medicine.2022;[Epub]     CrossRef
• The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review
  Aikaterini Eleftheriadou, Scott Williams, Sarah Nevitt, Emily Brown, Rebecca Roylance, John P. H. Wilding, Daniel J. Cuthbertson, Uazman Alam
  Diabetologia.2021; 64(2): 288.     CrossRef
• Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross‐sectional study
  Ernesto Maddaloni, Chiara Moretti, Rossella Del Toro, Sara Sterpetti, Maria Vittoria Ievolella, Gabriele Arnesano, Rocky Strollo, Silvia Irina Briganti, Luca D'Onofrio, Paolo Pozzilli, Raffaella Buzzetti
  Diabetic Medicine.2021;[Epub]     CrossRef
• Effects of lunar cycle on fasting plasma glucose, heart rate and blood pressure in type 2 diabetic patients
  Sutanu Dutta Chowdhury, Subhasish Pramanik, Koena Bhattacharjee, Lakshmi Kanta Mondal
  Chronobiology International.2021; 38(2): 270.     CrossRef
• Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial
  Yaling Tang, Hetal Shah, Carlos Roberto Bueno Junior, Xiuqin Sun, Joanna Mitri, Maria Sambataro, Luisa Sambado, Hertzel C. Gerstein, Vivian Fonseca, Alessandro Doria, Rodica Pop-Busui
  Diabetes Care.2021; 44(1): 164.     CrossRef
• Decreased glomerular filtration rate and increased albuminuria for identification of cardiovascular autonomic neuropathy in subjects with and without diabetes
  Ying-Chuen Lai, Hung-Yuan Li, Yi-Dier Jiang, Tien-Jyun Chang, Lee-Ming Chuang
  Autonomic Neuroscience.2021; 230: 102757.     CrossRef
• Exposures influencing the developing central autonomic nervous system
  Sarah D. Schlatterer, Adre J. du Plessis
  Birth Defects Research.2021; 113(11): 845.     CrossRef
• Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial
  Triantafyllos Didangelos, Eleni Karlafti, Evangelia Kotzakioulafi, Eleni Margariti, Parthena Giannoulaki, Georgios Batanis, Solomon Tesfaye, Kοnstantinos Kantartzis
  Nutrients.2021; 13(2): 395.     CrossRef
• The Association Between Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes
  Min Young Kim, Gyuri Kim, Ji Yun Park, Min Sun Choi, Ji Eun Jun, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
  Diabetes Technology & Therapeutics.2021; 23(6): 434.     CrossRef
• Insulin resistance is independently associated with cardiovascular autonomic neuropathy in type 2 diabetes
  Yingshan Liu, Yu Peng, Jing Jin, Yanshan Chen, Chuna Chen, Zhenguo Chen, Haishan Huang, Lingling Xu
  Journal of Diabetes Investigation.2021; 12(9): 1651.     CrossRef
• SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement
  Vincenza Spallone, Paul Valensi
  Diabetes & Metabolism.2021; 47(4): 101224.     CrossRef
• Reduction of Pressure Pain Sensitivity as Novel Non-pharmacological Therapeutic Approach to Type 2 Diabetes: A Randomized Trial
  Jens Faber, Ebbe Eldrup, Christian Selmer, Caroline Pichat, Sofie Korsgaard Hecquet, Torquil Watt, Svend Kreiner, Benny Karpatschof, Finn Gyntelberg, Søren Ballegaard, Albert Gjedde
  Frontiers in Neuroscience.2021;[Epub]     CrossRef
• Relationship between cardiac autonomic neuropathy and cardio-metabolic risk profile in adults with type 1 diabetes
  M. Serdarova, R. Dimova, N. Chakarova, G. Grozeva, A. Todorova, T. Tankova
  Diabetes Research and Clinical Practice.2021; 174: 108721.     CrossRef
• Differences and Similarities in Neuropathy in Type 1 and 2 Diabetes: A Systematic Review
  Mar Sempere-Bigorra, Iván Julián-Rochina, Omar Cauli
  Journal of Personalized Medicine.2021; 11(3): 230.     CrossRef
• Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives
  Ditte S. Kornum, Astrid J. Terkelsen, Davide Bertoli, Mette W. Klinge, Katrine L. Høyer, Huda H. A. Kufaishi, Per Borghammer, Asbjørn M. Drewes, Christina Brock, Klaus Krogh
  Journal of Clinical Medicine.2021; 10(7): 1392.     CrossRef
• Diabetic heart disease: A clinical update
  Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, Beverly Xin Yi Yeap, Joseph M Pappachan
  World Journal of Diabetes.2021; 12(4): 383.     CrossRef
• Novel and Emerging Electrophysiological Biomarkers of Diabetic Neuropathy and Painful Diabetic Neuropathy
  Anne Marshall, Uazman Alam, Andreas Themistocleous, Nigel Calcutt, Andrew Marshall
  Clinical Therapeutics.2021; 43(9): 1441.     CrossRef
• Cardiac Autonomic Neuropathy Is Not Reversed by Euglycemia Following Islet Transplantation
  Tejas Deshmukh, Peter Emerson, Patricia Anderson, Eddy Kizana, Philip J. O’Connell, D. Jane Holmes-Walker, James J.H. Chong
  Transplantation.2021; 105(5): 1125.     CrossRef
• Attenuation of Muscle Mass and Density Is Associated With Poor Outcomes Among Patients Undergoing Major Gynecologic Surgery: A Retrospective Cohort Study
  Lu Che, Yan Zhang, Jiawen Yu, Li Xu, Yuguang Huang
  Anesthesia & Analgesia.2021; 132(6): 1692.     CrossRef
• Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy
  Min Sun Choi, Ji Eun Jun, Sung Woon Park, Jee Hee Yoo, Jiyeon Ahn, Gyuri Kim, Sang-Man Jin, Kyu Yeon Hur, Moon-Kyu Lee, Jae Hyeon Kim
  Diabetes & Metabolism Journal.2021; 45(3): 349.     CrossRef
• Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
  Gordon Sloan, Dinesh Selvarajah, Solomon Tesfaye
  Nature Reviews Endocrinology.2021; 17(7): 400.     CrossRef
• Heart Rate Variability as a Potential Non-invasive Marker of Blood Glucose Level
  L. R. Jarman, J. L. Elliott, T. Lees, R. Clifton-Bligh, A. M. Simpson, N. Nassif, S. Lal
  Human Physiology.2021; 47(2): 209.     CrossRef
• Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications
  Alice Duque, Mauro Felippe Felix Mediano, Andrea De Lorenzo, Luiz Fernando Rodrigues Jr
  World Journal of Diabetes.2021; 12(6): 855.     CrossRef
• Gaussian process-based kernel as a diagnostic model for prediction of type 2 diabetes mellitus risk using non-linear heart rate variability features
  R. Shashikant, Uttam Chaskar, Leena Phadke, Chetankumar Patil
  Biomedical Engineering Letters.2021; 11(3): 273.     CrossRef
• Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis
  Vincenzo Maria Monda, Francesca Porcellati, Felice Strollo, Alessandro Fucili, Marcello Monesi, Ersilia Satta, Sandro Gentile
  Advances in Therapy.2021; 38(8): 4195.     CrossRef
• Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus
  Amanda Hempel Zinglersen, Katrine Kjær Iversen, Henrik Christian Bidstrup Leffers, Esben Laugesen, Jesper Fleischer, Søren Jacobsen
  Lupus Science & Medicine.2021; 8(1): e000507.     CrossRef
• Impaired vagal adaptation to an exercise task in women with gestational diabetes mellitus versus women with uncomplicated pregnancies
  Marieta P. Theodorakopoulou, Areti Triantafyllou, Andreas Zafeiridis, Afroditi Κ. Boutou, Iris Grigoriadou, Evangelia Kintiraki, Stella Douma, Dimitrios G. Goulis, Konstantina Dipla
  Hormones.2021; 20(4): 753.     CrossRef
• Cardioprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors Regardless of Type 2 Diabetes Mellitus: A Meta-analysis
  Lucas Silva Sousa, Felipe de Araújo Nascimento, Juliano Rocha, Michelle Rocha-Parise
  International Journal of Cardiovascular Sciences.2021;[Epub]     CrossRef
• Management of diabetic neuropathy
  Simona Cernea, Itamar Raz
  Metabolism.2021; 123: 154867.     CrossRef
• Large fibre, small fibre and autonomic neuropathy in adolescents with type 1 diabetes: A systematic review
  Vinni Faber Rasmussen, Troels Staehelin Jensen, Hatice Tankisi, Páll Karlsson, Esben Thyssen Vestergaard, Kurt Kristensen, Jens Randel Nyengaard, Astrid Juhl Terkelsen
  Journal of Diabetes and its Complications.2021; 35(11): 108027.     CrossRef
• Cardiovascular Risk Management in Type 1 Diabetes
  I. H. Teoh, P. Elisaus, J. D. Schofield
  Current Diabetes Reports.2021;[Epub]     CrossRef
• Disturbances in the intraventricular conduction system in teenagers with type 1 diabetes. A pilot study
  Agnieszka Zubkiewicz-Kucharska, Anna Noczyńska, Małgorzata Sobieszczańska, Małgorzata Poręba, Joanna Chrzanowska, Rafał Poręba, Monika Seifert, Anna Janocha, Krystyna Laszki-Szcząchor
  Journal of Diabetes and its Complications.2021; 35(11): 108043.     CrossRef
• Peripheral and Autonomic Neuropathy Status of Young Patients With Type 1 Diabetes Mellitus at the Time of Transition From Pediatric Care to Adult-Oriented Diabetes Care
  Anna Vágvölgyi, Ágnes Maróti, Mónika Szűcs, Csongor Póczik, Dóra Urbán-Pap, István Baczkó, Attila Nemes, Éva Csajbók, Krisztián Sepp, Péter Kempler, Andrea Orosz, Tamás Várkonyi, Csaba Lengyel
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Pancreatic exocrine insufficiency in diabetes is associated with autonomic dysfunction
  Dag André Sangnes, Elisabeth Sandvik Bergmann, Rose Marie Moss, Trond Engjom, Eirik Søfteland
  Scandinavian Journal of Gastroenterology.2021; 56(10): 1222.     CrossRef
• Dependence of Heart Rate Variability Indices on the Mean Heart Rate in Women with Well-Controlled Type 2 Diabetes
  Adriana Robles-Cabrera, José M. Torres-Arellano, Ruben Fossion, Claudia Lerma
  Journal of Clinical Medicine.2021; 10(19): 4386.     CrossRef
• Normative data on cardiovascular autonomic function in Greenlandic Inuit
  Marie Mathilde Bjerg Christensen, Christian Stevns Hansen, Jesper Fleischer, Dorte Vistisen, Stine Byberg, Trine Larsen, Jens Christian Laursen, Marit Eika Jørgensen
  BMJ Open Diabetes Research & Care.2021; 9(1): e002121.     CrossRef
• What Is in the Field for Genetics and Epigenetics of Diabetic Neuropathy: The Role of MicroRNAs
  V. Spallone, C. Ciccacci, A. Latini, P. Borgiani, Karim Gariani
  Journal of Diabetes Research.2021; 2021: 1.     CrossRef
• Evaluation and treatment of peripheral nervous system dysfunction in patients with prediabetes
  O. E. Zinovyeva, T. M. Ostroumova, M. V. Koniashova, N. A. Gorbachev
  Neurology, Neuropsychiatry, Psychosomatics.2021; 13(5): 116.     CrossRef
• Manifestazioni cliniche della neuropatia autonomica diabetica: valutazione dei sintomi
  Carla Greco, Chiara Pacchioni, Manuela Simoni
  L'Endocrinologo.2021; 22(6): 514.     CrossRef
• Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review
  Xiaochun Zhang, Xue Yang, Bao Sun, Chunsheng Zhu
  Communications Biology.2021;[Epub]     CrossRef
• The Association Between Cardiovascular Autonomic Function and Changes in Kidney and Myocardial Function in Type 2 Diabetes and Healthy Controls
  Jens Christian Laursen, Ida Kirstine B. Rasmussen, Emilie H. Zobel, Philip Hasbak, Bernt Johan von Scholten, Lene Holmvang, Rasmus S. Ripa, Christian S. Hansen, Marie Frimodt-Moeller, Andreas Kjaer, Peter Rossing, Tine W. Hansen
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Dependence of heart rate variability on indicators of type 1 diabetes mellitus control.
  N. O. Pertseva, O. V. Gurzhiy, K. I. Moshenets
  Medicni perspektivi (Medical perspectives).2020; 25(1): 88.     CrossRef
• Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study)
  Gyuri Kim, Soo Lim, Hyuk‐Sang Kwon, Ie B. Park, Kyu J. Ahn, Cheol‐Young Park, Su K. Kwon, Hye S. Kim, Seok W. Park, Sin G. Kim, Min K. Moon, Eun S. Kim, Choon H. Chung, Kang S. Park, Mikyung Kim, Dong J. Chung, Chang B. Lee, Tae H. Kim, Moon‐Kyu Lee
  Diabetes, Obesity and Metabolism.2020; 22(9): 1527.     CrossRef
• Diabetes mellitus and comorbidities: A bad romance
  Niki Katsiki, Dimitrios Tousoulis
  Hellenic Journal of Cardiology.2020; 61(1): 23.     CrossRef
• Features of the glucose influence on the heart activity and the changes in the potentials of the stomach and the intestines at the heart insufficiency conditions
  V. V. Soltanov, L. M. Komarovskaya
  Doklady of the National Academy of Sciences of Belarus.2020; 63(6): 736.     CrossRef
• Living Day to Day
  Gerald Kayingo, Virginia McCoy Hass
  Physician Assistant Clinics.2020; 5(2): 213.     CrossRef
• Source specific PM2.5 associated with heart rate variability in the elderly with coronary heart disease: A community-based panel study
  Xi Chen, Bing Qiu, Qinpei Zou, Tian Qiu, Runkui Li, Ashley Truong, Yanmin Qi, Tao Liu, Limin Han, Tiebing Liu, Junrui Chang, Qi Sun, Ying Zhu, Dongqun Xu
  Chemosphere.2020; 260: 127399.     CrossRef
• The Association of Autonomic Nervous System Function With Ischemic Stroke, and Treatment Strategies
  Mengxi Zhao, Ling Guan, Yilong Wang
  Frontiers in Neurology.2020;[Epub]     CrossRef
• Cardiac diabetic autonomic neuropathy
  L. T. Akhmedzhanova, T. A. Belyakova, Yu. A. Podkovko, Yu. M. Shor
  Medical Council.2020; (21): 94.     CrossRef
• Diabetes, and its treatment, as an effector of autonomic nervous system circuits and its functions
  Liliana Espinoza, Carie R Boychuk
  Current Opinion in Pharmacology.2020; 54: 18.     CrossRef
• Morning blood pressure surge is associated with autonomic neuropathy and peripheral vascular disease in patients with diabetes
  Federica Di Gennaro, Cinzia D’Amato, Roberto Morganti, Carla Greco, Susanna Longo, Diana Corradini, Davide Lauro, Vincenza Spallone
  Journal of Human Hypertension.2020; 34(7): 495.     CrossRef
• The Compound Expression of HSP90 and INOS in the Testis of Diabetic Rats as Cellular and Pathologic Adverse Effects of Diabetes
  Ali Alsarhan, Kawther Faisal Amawi, Inas Saleh Al-Mazari, Hashem Abu Hurirah, Ahed J. Alkhatib
  Analytical Cellular Pathology.2020; 2020: 1.     CrossRef
• Heart rate variability features from nonlinear cardiac dynamics in identification of diabetes using artificial neural network and support vector machine
  Yogender Aggarwal, Joyani Das, Papiya Mitra Mazumder, Rohit Kumar, Rakesh Kumar Sinha
  Biocybernetics and Biomedical Engineering.2020; 40(3): 1002.     CrossRef
• Distal Symmetric and Cardiovascular Autonomic Neuropathies in Brazilian Individuals with Type 2 Diabetes Followed in a Primary Health Care Unit: A Cross-Sectional Study
  Mozania Reis de Matos, Daniele Pereira Santos-Bezerra, Cristiane das Graças Dias Cavalcante, Jacira Xavier de Carvalho, Juliana Leite, Jose Antonio Januario Neves, Sharon Nina Admoni, Marisa Passarelli, Maria Candida Parisi, Maria Lucia Correa-Giannella
  International Journal of Environmental Research and Public Health.2020; 17(9): 3232.     CrossRef
• Awareness of hypoglycemia and spectral analysis of heart rate variability in type 1 diabetes
  Ticiana Paes, L. Clemente Rolim, Celso Sallum Filho, João Roberto de Sa, Sérgio A. Dib
  Journal of Diabetes and its Complications.2020; 34(8): 107617.     CrossRef
• Is there cardiac autonomic neuropathy in prediabetes?
  Lindsay A. Zilliox, James W. Russell
  Autonomic Neuroscience.2020; 229: 102722.     CrossRef
• Chronic Microvascular Complications in Prediabetic States—An Overview
  Angelika Baranowska-Jurkun, Wojciech Matuszewski, Elżbieta Bandurska-Stankiewicz
  Journal of Clinical Medicine.2020; 9(10): 3289.     CrossRef
• Cardiac vagal tone as a novel screening tool to recognize asymptomatic cardiovascular autonomic neuropathy: Aspects of utility in type 1 diabetes
  Anne-Marie Wegeberg, Elin D Lunde, Sam Riahi, Niels Ejskjaer, Asbjørn M Drewes, Birgitte Brock, Rodica Pop-Busui, Christina Brock
  Diabetes Research and Clinical Practice.2020; 170: 108517.     CrossRef
• Assessment of baroreceptor reflex sensitivity in young obese Saudi males at rest and in response to physiological challenges
  Abdullah N. AlShahrani, Lubna I. Al‐Asoom, Ahmed A. Alsunni, Nabil S. Elbahai, Talay Yar
  Physiological Reports.2020;[Epub]     CrossRef
• The relationship between QT interval indices with cardiac autonomic neuropathy in diabetic patients: a case control study
  Maryam Vasheghani, Farzaneh Sarvghadi, Mohammad Reza Beyranvand, Habib Emami
  Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
• Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options
  Péter Bencsik, Kamilla Gömöri, Tamara Szabados, Péter Sántha, Zsuzsanna Helyes, Gábor Jancsó, Péter Ferdinandy, Anikó Görbe
  British Journal of Pharmacology.2020; 177(23): 5336.     CrossRef
• Biological Activity of c-Peptide in Microvascular Complications of Type 1 Diabetes—Time for Translational Studies or Back to the Basics?
  Aleksandra Ryk, Aleksandra Łosiewicz, Arkadiusz Michalak, Wojciech Fendler
  International Journal of Molecular Sciences.2020; 21(24): 9723.     CrossRef
• Diabetes and cardiovascular disease: inter-relation of risk factors and treatment
  Aman Sharma, Shweta Mittal, Rohan Aggarwal, Meenakshi K. Chauhan
  Future Journal of Pharmaceutical Sciences.2020;[Epub]     CrossRef
• Diabetic Autonomic Neuropathy: A Clinical Update
  Jugal Kishor Sharma, Anshu Rohatgi, Dinesh Sharma
  Journal of the Royal College of Physicians of Edinburgh.2020; 50(3): 269.     CrossRef
• Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus
  Niki Katsiki, Panagiotis Anagnostis, Kalliopi Kotsa, Dimitrios G. Goulis, Dimitri P. Mikhailidis
  Current Pharmaceutical Design.2019; 25(18): 2051.     CrossRef
• Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review
  Scott M. Williams, Aikaterini Eleftheriadou, Uazman Alam, Daniel J. Cuthbertson, John P. H. Wilding
  Diabetes Therapy.2019; 10(6): 1995.     CrossRef

The glucagon-like peptide-1 receptor agonists (GLP-1RAs) were recommended as a monotherapy or combination therapy with oral hypoglycemic agents or basal insulin in the position statement of the Korean Diabetes Association 2017 for pharmacological therapy. Many randomized clinical trials and systematic reviews report that GLP-1RAs have considerable glucose-lowering effect and lead to weight reduction and low risk of hypoglycemia when used as a monotherapy or combination therapy. The cardiovascular safety of GLP-1RAs has been assessed in several randomized clinical trials and systematic reviews. The results of cardiovascular outcome trials of long-acting GLP-1RAs (liraglutide, semaglutide) demonstrated cardiovascular benefits in subjects with type 2 diabetes mellitus and a high risk of cardiovascular disease. The GLP-1RA may be a choice of therapy when weight control and avoidance of hypoglycemia are important, and patients with high risk of cardiovascular disease might also favor choosing GLP-1RA.

Citations

Citations to this article as recorded by  

• Anti-inflammatory effect of glucagon-like Peptide-1 receptor agonist on the neurosensory retina in an acute optic nerve injury rat model
  Yeon Woong Chung, Ji Young Lee, Hyun Hee Ju, Jin A. Choi
  European Journal of Pharmacology.2022; 933: 175269.     CrossRef
• Diabetes Risk Data Mining Method Based on Electronic Medical Record Analysis
  Yang Liu, Zhaoxiang Yu, Yunlong Yang, Zhihan Lv
  Journal of Healthcare Engineering.2021; 2021: 1.     CrossRef
• Paradigm Shift for the Treatment of Type 2 Diabetes Mellitus in Patients with Cardiovascular Disease: Cardiologist's Perspective
  Doo Soo Jeon
  Cardiovascular Prevention and Pharmacotherapy.2020; 2(1): 11.     CrossRef
• The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
  Ju-Ming Lu
  Advances in Therapy.2019; 36(4): 798.     CrossRef
• A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes
  Irene Romera, Ana Cebrián-Cuenca, Fernando Álvarez-Guisasola, Fernando Gomez-Peralta, Jesús Reviriego
  Diabetes Therapy.2019; 10(1): 5.     CrossRef
• Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
  Hyun Jin Kim
  The Journal of Korean Diabetes.2018; 19(1): 35.     CrossRef

Type 2 diabetes mellitus (T2DM) is a multifactorial disease with a complex and progressive pathogenesis. The two primary mechanisms of T2DM pathogenesis are pancreatic β-cell dysfunction and insulin resistance. Pancreatic β-cell dysfunction is recognized to be a prerequisite for the development of T2DM. Therapeutic modalities that improve β-cell function are considered critical to T2DM management; however, blood glucose control remains a challenge for many patients due to suboptimal treatment efficacy and the progressive nature of T2DM. Incretin-based therapies are now the most frequently prescribed antidiabetic drugs in Korea. Incretin-based therapies are a favorable class of drugs due to their ability to reduce blood glucose by targeting the incretin hormone system and, most notably, their potential to improve pancreatic β-cell function. This review outlines the current understanding of the incretin hormone system in T2DM and summarizes recent updates on the effect of incretin-based therapies on β-cell function and β-cell mass in animals and humans.

Citations

Citations to this article as recorded by  

• The AMPK-SIRT1 Axis: Redefining type 2 diabetes mellitus management
  Mighty Kemelo, Phillip Moseki
  Results in Chemistry.2025; 14: 102139.     CrossRef
• Cyanidin-3-O-glucoside enhances GLP-1 secretion via PPARβ/δ-β-catenin-TCF-4 pathway in type 2 diabetes mellitus
  Xiang Ye, Wen Chen, Fujie Yan, Xiaodong Zheng, Pengcheng Tu
  npj Science of Food.2025;[Epub]     CrossRef
• Local Insulin for Local Needs? Insights into Retinal Insulin Signaling and RPE Metabolism
  Matilde Balbi, Alessandra Puddu, Andrea Amaroli, Davide Maggi, Isabella Panfoli, Silvia Ravera
  Biomolecules.2025; 15(11): 1570.     CrossRef
• Scars of oxidative stress: protein carbonylation and beta cell dysfunction in diabetes
  Ashley Ling, Katherine R. Schultz, Jefferson D. Knight, Colin T. Shearn, Sharon Baumel-Alterzon
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• GLP-1 Analogue-Loaded Glucose-Responsive Nanoparticles as Allies of Stem Cell Therapies for the Treatment of Type I Diabetes
  Joana Moreira Marques, Rute Nunes, Ana Margarida Carvalho, Helena Florindo, Domingos Ferreira, Bruno Sarmento
  ACS Pharmacology & Translational Science.2024; 7(5): 1650.     CrossRef
• Bisphenol a accelerates the glucolipotoxicity-induced dysfunction of rat insulinoma cell lines: An implication for a potential risk of environmental bisphenol a exposure for individuals susceptible to type 2 diabetes
  Chengmeng Huang, Xiaolin Chen, Zedong Ouyang, Lingxue Meng, Jian Liu, Qihua Pang, Ruifang Fan
  Toxicology in Vitro.2024; 99: 105866.     CrossRef
• Harnessing gut cells for functional insulin production: Strategies and challenges
  Kelvin Baafi, John C. March
  Biotechnology Notes.2023; 4: 7.     CrossRef
• Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
  Chang Ho Ahn, Tae Jung Oh, Se Hee Min, Young Min Cho
  Endocrinology and Metabolism.2023; 38(1): 1.     CrossRef
• Weight loss maintenance with exercise and liraglutide improves glucose tolerance, glucagon response, and beta cell function
  Simon B. K. Jensen, Christian R. Juhl, Charlotte Janus, Julie R. Lundgren, Christoffer Martinussen, Christoffer Wiingaard, Cecilie Knudsen, Ruth Frikke‐Schmidt, Bente M. Stallknecht, Jens J. Holst, Sten Madsbad, Signe S. Torekov
  Obesity.2023; 31(4): 977.     CrossRef
• How do parasitic worms prevent diabetes? An exploration of their influence on macrophage and β-cell crosstalk
  Inah Camaya, Bronwyn O’Brien, Sheila Donnelly
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• An Imbalance of Pathophysiologic Factors in Late Postprandial Hypoglycemia Post Bariatric Surgery: A Narrative Review
  Marah Alsayed Hasan, Stanley Schwartz, Victoria McKenna, Richard Ing
  Obesity Surgery.2023; 33(9): 2927.     CrossRef
• Therapeutic Dilemma in Personalized Medicine
  Ehab S. EL Desoky
  Current Reviews in Clinical and Experimental Pharmacology.2022; 17(2): 94.     CrossRef
• Lessons from neonatal β-cell epigenomic for diabetes prevention and treatment
  Amar Abderrahmani, Cécile Jacovetti, Romano Regazzi
  Trends in Endocrinology & Metabolism.2022; 33(6): 378.     CrossRef
• Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists
  Neil Tanday, Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
  Diabetes, Obesity and Metabolism.2022; 24(12): 2353.     CrossRef
• A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes
  Chih-Yuan Wang, Kuo-Chin Huang, Chia-Wen Lu, Chih-Hsun Chu, Chien-Ning Huang, Harn-Shen Chen, I-Te Lee, Jung-Fu Chen, Ching-Chu Chen, Chung-Sen Chen, Chang-Hsun Hsieh, Kai-Jen Tien, Hung-Yu Chien, Yu-Yao Huang, Jui-Pao Hsu, Guang-Tzuu Shane, Ai-Ching Chan
  The Journal of Clinical Endocrinology & Metabolism.2022; 107(10): e4063.     CrossRef
• Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study
  Tao Tao, Yi Zhang, Yu-Chen Zhu, Jia-Rong Fu, Yu-Ying Wang, Jie Cai, Jing-Yu Ma, Yu Xu, Yi-Ning Gao, Yun Sun, WuQiang Fan, Wei Liu
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(3): e1420.     CrossRef
• The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study
  Tuccinardi Dario, Giorgino Riccardo, Pieralice Silvia, Watanabe Mikiko, Maggi Daria, Palermo Andrea, Defeudis Giuseppe, Fioriti Elvira, Pozzilli Paolo, Manfrini Silvia
  Acta Diabetologica.2021; 58(4): 411.     CrossRef
• Type 2 diabetes: evidence-based medicine approach to glucose-lowering therapy
  E. V. Biryukova, I. A. Morozova, S. V. Rodionova
  Meditsinskiy sovet = Medical Council.2021; (21): 160.     CrossRef
• Emerging Role of Caveolin-1 in GLP-1 Action
  Alessandra Puddu, Davide Maggi
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Improvements in HOMA indices and pancreatic endocrinal tissues in type 2-diabetic rats by DPP-4 inhibition and antioxidant potential of an ethanol fruit extract of Withania coagulans
  Heera Ram, Pramod Kumar, Ashok Purohit, Priya Kashyap, Suresh Kumar, Shivani Kumar, Garima Singh, Abdulaziz A. Alqarawi, Abeer Hashem, Elsayed Fathi Abd-Allah, Al-Bandari Fahad Al-Arjani, Bhim Pratap Singh
  Nutrition & Metabolism.2021;[Epub]     CrossRef
• Chop / Ddit3 depletion in β cells alleviates ER stress and corrects hepatic steatosis in mice
  Jing Yong, Vishal S. Parekh, Shannon M. Reilly, Jonamani Nayak, Zhouji Chen, Cynthia Lebeaupin, Insook Jang, Jiangwei Zhang, Thazha P. Prakash, Hong Sun, Sue Murray, Shuling Guo, Julio E. Ayala, Leslie S. Satin, Alan R. Saltiel, Randal J. Kaufman
  Science Translational Medicine.2021;[Epub]     CrossRef
• Assessment of Insulin Secretion and Insulin Resistance in Human
  So Young Park, Jean-François Gautier, Suk Chon
  Diabetes & Metabolism Journal.2021; 45(5): 641.     CrossRef
• Targeted pharmacological therapy restores β-cell function for diabetes remission
  Stephan Sachs, Aimée Bastidas-Ponce, Sophie Tritschler, Mostafa Bakhti, Anika Böttcher, Miguel A. Sánchez-Garrido, Marta Tarquis-Medina, Maximilian Kleinert, Katrin Fischer, Sigrid Jall, Alexandra Harger, Erik Bader, Sara Roscioni, Siegfried Ussar, Annett
  Nature Metabolism.2020; 2(2): 192.     CrossRef
• The Relationship Between Timing of Initiation on a Glucagon-like Peptide-1 Receptor Agonist and Glycosylated Hemoglobin Values Among Patients With Type 2 Diabetes
  Kristina S. Boye, Reema Mody, Maureen J. Lage, Raleigh E. Malik
  Clinical Therapeutics.2020; 42(9): 1812.     CrossRef
• Short-term renal and metabolic effects of low dose vildagliptin treatment added-on insulin therapy in non-proteinuric patients with type 2 diabetes: open-label randomized prospective study
  Valentina K. Bayrasheva, Ivan Y. Pchelin, Vladimir A. Dobronravov, Alina Yu. Babenko, Svetlana G. Chefu, Ivan S. Shatalov, Volha N. Vasilkova, Natalia V. Hudiakova, Alexandra N. Ivanova, Pavel A. Andoskin, Elena N. Grineva
  Archives of Endocrinology and Metabolism.2020;[Epub]     CrossRef
• A Phenotypic Screen Identifies Calcium Overload as a Key Mechanism of β-Cell Glucolipotoxicity
  Jennifer Vogel, Jianning Yin, Liansheng Su, Sharon X. Wang, Richard Zessis, Sena Fowler, Chun-Hao Chiu, Aaron C. Wilson, Amy Chen, Frederic Zecri, Gordon Turner, Thomas M. Smith, Brian DeChristopher, Heming Xing, Deborah M. Rothman, Xinming Cai, Alina Ber
  Diabetes.2020; 69(5): 1032.     CrossRef
• Neuropeptide 26RFa (QRFP) is a key regulator of glucose homeostasis and its activity is markedly altered in obese/hyperglycemic mice
  Gaëtan Prévost, Arnaud Arabo, Marie-Anne Le Solliec, Justine Bons, Marie Picot, Julie Maucotel, Hind Berrahmoune, Mouna El Mehdi, Saloua Cherifi, Alexandre Benani, Emmanuelle Nédélec, Moïse Coëffier, Jérôme Leprince, Anneli Nordqvist, Valéry Brunel, Pierr
  American Journal of Physiology-Endocrinology and Metabolism.2019; 317(1): E147.     CrossRef
• Gastrin analogue administration adds no significant glycaemic benefit to a glucagon‐like peptide‐1 receptor agonist acutely or after washout of both analogues
  Krister Bokvist, Ying Ding, William H. Landschulz, Vikram Sinha, Aleksandra Pastrak, Ruth M. Belin
  Diabetes, Obesity and Metabolism.2019; 21(7): 1606.     CrossRef
• Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1
  Lie-Chwen Lin, Lin-Chien Lee, Cheng Huang, Chiung-Tong Chen, Jen-Shin Song, Young-Ji Shiao, Hui-Kang Liu
  Phytomedicine.2019; 62: 152946.     CrossRef
• The future of new drugs for diabetes management
  Clifford J. Bailey, Caroline Day
  Diabetes Research and Clinical Practice.2019; 155: 107785.     CrossRef
• Compact fluidic system for functional assessment of pancreatic islets
  Takeshi Hori, Kei Yamane, Takayuki Anazawa, Osamu Kurosawa, Hiroo Iwata
  Biomedical Microdevices.2019;[Epub]     CrossRef
• Pharmacokinetics of Exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and Bydureon
  Yazhou Li, Kelli L. Vaughan, David Tweedie, Jin Jung, Hee Kyung Kim, Ho-Il Choi, Dong Seok Kim, Julie A. Mattison, Nigel H. Greig
  Scientific Reports.2019;[Epub]     CrossRef
• Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury
  Miaad Bader, Yazhou Li, Daniela Lecca, Vardit Rubovitch, David Tweedie, Elliot Glotfelty, Lital Rachmany, Hee Kyung Kim, Ho-Il Choi, Barry J. Hoffer, Chaim G. Pick, Nigel H. Greig, Dong Seok Kim
  Neurobiology of Disease.2019; 124: 439.     CrossRef
• Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential
  N.M. Pathak, V. Pathak, V.A. Gault, S. McClean, N. Irwin, P.R. Flatt
  Biochemical Pharmacology.2018; 155: 264.     CrossRef
• Human EndoC-βH1 β-cells form pseudoislets with improved glucose sensitivity and enhanced GLP-1 signaling in the presence of islet-derived endothelial cells
  Michael G. Spelios, Lauren A. Afinowicz, Regine C. Tipon, Eitan M. Akirav
  American Journal of Physiology-Endocrinology and Metabolism.2018; 314(5): E512.     CrossRef
• Vildagliptin: ten years in the service for type 2 diabetes mellitus patients. The journey of discovery, innovation and success in clinical practice
  Tatiana Yu. Demidova
  Problems of Endocrinology.2018; 64(5): 336.     CrossRef
• Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss
  Paola Simeone, Rossella Liani, Romina Tripaldi, Augusto Di Castelnuovo, Maria Teresa Guagnano, Armando Tartaro, Riccardo C. Bonadonna, Virginia Federico, Francesco Cipollone, Agostino Consoli, Francesca Santilli
  Nutrients.2018; 10(12): 1872.     CrossRef
• Nutrient regulation of β-cell function: what do islet cell/animal studies tell us?
  R Carlessi, K N Keane, C Mamotte, P Newsholme
  European Journal of Clinical Nutrition.2017; 71(7): 890.     CrossRef
• Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice
  You-Cheol Hwang, Ari Kim, Euna Jo, Yeoree Yang, Jae-Hyoung Cho, Byung-Wan Lee
  BMC Endocrine Disorders.2017;[Epub]     CrossRef
• Efficacy and safety of adding evogliptin versus sitagliptin for metformin‐treated patients with type 2 diabetes: A 24‐week randomized, controlled trial with open label extension
  Sang‐Mo Hong, Cheol‐Young Park, Dong‐Min Hwang, Kyung Ah Han, Chang Beom Lee, Choon Hee Chung, Kun‐Ho Yoon, Ji‐Oh Mok, Kyong Soo Park, Sung‐Woo Park
  Diabetes, Obesity and Metabolism.2017; 19(5): 654.     CrossRef
• The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)
  Naoyuki Kitao, Hideaki Miyoshi, Tomoo Furumoto, Kota Ono, Hiroshi Nomoto, Aika Miya, Chiho Yamamoto, Atsushi Inoue, Kenichi Tsuchida, Naoki Manda, Yoshio Kurihara, Shin Aoki, Akinobu Nakamura, Tatsuya Atsumi
  Cardiovascular Diabetology.2017;[Epub]     CrossRef
• Recent Advances in Effect‐directed Enzyme Assays based on Thin‐layer Chromatography
  Sarah Bräm, Evelyn Wolfram
  Phytochemical Analysis.2017; 28(2): 74.     CrossRef
• Efficacy and safety of gemigliptin, a dipeptidyl peptidase‐4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24‐week, multicentre, randomized, double‐blind, placebo‐
  Chang Ho Ahn, Kyung Ah Han, Jae Myung Yu, Joo Young Nam, Kyu Jeung Ahn, Tae Keun Oh, Hyoung Woo Lee, Dae Ho Lee, Jaetaek Kim, Choon Hee Chung, Tae Sun Park, Byung Joon Kim, Seok Won Park, Hyeong Kyu Park, Kwang Jae Lee, Sang‐Wook Kim, Jeong Hyun Park, Kwa
  Diabetes, Obesity and Metabolism.2017; 19(5): 635.     CrossRef
• Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  The Korean Journal of Internal Medicine.2017; 32(6): 947.     CrossRef
• Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  Diabetes & Metabolism Journal.2017; 41(5): 337.     CrossRef
• DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control
  Eun Ju Bae
  Archives of Pharmacal Research.2016; 39(8): 1114.     CrossRef
• Liraglutide Enhances the Efficacy of Human Mesenchymal Stem Cells in Preserving Islet ß-cell Function in Severe Non-obese Diabetic Mice
  Li-rong Li, Jing Lu, Xiao-lei Jia, Hui Hui, Jie Zhang, Ying Liu, Wei-juan Cui, Qian-yue Xu, Da-long Zhu
  Molecular Medicine.2016; 22(1): 800.     CrossRef

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce glycosylated hemoglobin (HbA1c, 0.5% to 1.0%), and are associated with moderate weight loss and a relatively low risk of hypoglycemia. There are differences between Asian and non-Asian populations. We reviewed available data on GLP-1RAs, focusing on Korean patients, to better understand their risk/benefit profile and help inform local clinical practice. Control of postprandial hyperglycemia is important in Asians in whom the prevalence of post-challenge hyperglycemia is higher (vs. non-Asians). The weight lowering effects of GLP-1RAs are becoming more salient as the prevalence of overweight and obesity among Korean patients increases. The higher rate of gastrointestinal adverse events amongst Asian patients in clinical trials may be caused by higher drug exposure due to the lower body mass index of the participants (vs. non-Asian studies). Data on the durability of weight loss, clinically important health outcomes, safety and optimal dosing in Korean patients are lacking. Use of GLP-1RAs is appropriate in several patient groups, including patients whose HbA1c is uncontrolled, especially if this is due to postprandial glucose excursions and patients who are overweight or obese due to dietary problems (e.g., appetite control). The potential for gastrointestinal adverse events should be explained to patients at treatment initiation to facilitate the promotion of better compliance.

Citations

Citations to this article as recorded by  

• Safety and Effectiveness of Dulaglutide in the Treatment of Type 2 Diabetes Mellitus: A Korean Real-World Post-Marketing Study
  Jeonghee Han, Woo Je Lee, Kyu Yeon Hur, Jae Hyoung Cho, Byung Wan Lee, Cheol-Young Park
  Diabetes & Metabolism Journal.2024; 48(3): 418.     CrossRef
• Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
  Youngsook Kim, Ji Hye Huh, Minyoung Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  Diabetes & Metabolism Journal.2017; 41(5): 337.     CrossRef
• Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  The Korean Journal of Internal Medicine.2017; 32(6): 947.     CrossRef